FALSE 2020 Q3 0000731012--12-31 us-gaap:AccountingStandardsUpdate201613Member us-gaap:AccountingStandardsUpdate201613Member 0000731012 2020-01-01 2020-09-30 xbrli:shares 0000731012 2020-10-22 iso4217:USD 0000731012 2020-09-30 0000731012 2019-12-31 iso4217:USD xbrli:shares 0000731012 2020-07-01 2020-09-30 0000731012 2019-07-01 2019-09-30 0000731012 2019-01-01 2019-09-30 0000731012 2018-12-31 0000731012 2019-09-30 0000731012 us-gaap:CommonStockMember 2019-12-31 0000731012 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000731012 us-gaap:RetainedEarningsMember 2019-12-31 0000731012 us-gaap:TreasuryStockMember 2019-12-31 0000731012 2019-01-01 2019-12-31 0000731012 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000731012 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000731012 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000731012 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000731012 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000731012 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:RetainedEarningsMember 2019-12-31 0000731012 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:TreasuryStockMember 2019-12-31 0000731012 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000731012 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000731012 2020-01-01 2020-03-31 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000731012 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000731012 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000731012 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000731012 us-gaap:CommonStockMember 2020-03-31 0000731012 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000731012 us-gaap:RetainedEarningsMember 2020-03-31 0000731012 us-gaap:TreasuryStockMember 2020-03-31 0000731012 2020-03-31 0000731012 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0000731012 2020-04-01 2020-06-30 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0000731012 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0000731012 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000731012 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0000731012 us-gaap:CommonStockMember 2020-06-30 0000731012 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000731012 us-gaap:RetainedEarningsMember 2020-06-30 0000731012 us-gaap:TreasuryStockMember 2020-06-30 0000731012 2020-06-30 0000731012 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0000731012 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0000731012 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0000731012 us-gaap:TreasuryStockMember 2020-07-01 2020-09-30 0000731012 us-gaap:CommonStockMember 2020-09-30 0000731012 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0000731012 us-gaap:RetainedEarningsMember 2020-09-30 0000731012 us-gaap:TreasuryStockMember 2020-09-30 0000731012 us-gaap:CommonStockMember 2018-12-31 0000731012 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000731012 us-gaap:RetainedEarningsMember 2018-12-31 0000731012 us-gaap:TreasuryStockMember 2018-12-31 0000731012 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000731012 2019-01-01 2019-03-31 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000731012 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000731012 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000731012 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000731012 us-gaap:CommonStockMember 2019-03-31 0000731012 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000731012 us-gaap:RetainedEarningsMember 2019-03-31 0000731012 us-gaap:TreasuryStockMember 2019-03-31 0000731012 2019-03-31 0000731012 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000731012 2019-04-01 2019-06-30 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0000731012 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000731012 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000731012 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0000731012 us-gaap:CommonStockMember 2019-06-30 0000731012 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000731012 us-gaap:RetainedEarningsMember 2019-06-30 0000731012 us-gaap:TreasuryStockMember 2019-06-30 0000731012 2019-06-30 0000731012 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000731012 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0000731012 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000731012 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000731012 us-gaap:CommonStockMember 2019-09-30 0000731012 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000731012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000731012 us-gaap:RetainedEarningsMember 2019-09-30 0000731012 us-gaap:TreasuryStockMember 2019-09-30 0000731012 srt:MinimumMember 2020-01-01 2020-09-30 0000731012 srt:MaximumMember 2020-01-01 2020-09-30 hcsg:segment 0000731012 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 0000731012 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2020-01-01 hcsg:financial_institution 0000731012 hcsg:HousekeepingServicesMember 2020-01-01 2020-09-30 0000731012 hcsg:HousekeepingServicesMember 2019-01-01 2019-09-30 xbrli:pure 0000731012 hcsg:DietaryServicesMember 2020-01-01 2020-09-30 0000731012 hcsg:DietaryServicesMember 2019-01-01 2019-09-30 0000731012 us-gaap:TransferredAtPointInTimeMember 2020-09-30 0000731012 us-gaap:TransferredAtPointInTimeMember 2019-12-31 0000731012 2020-10-01 2020-09-30 0000731012 hcsg:StandardNoteReceivableMember 2020-09-30 0000731012 hcsg:ElevatedRiskNoteReceivableMember 2020-09-30 0000731012 hcsg:StandardNoteReceivableMember hcsg:FinancialAsset0To90DaysPastDueMember 2020-09-30 0000731012 hcsg:StandardNoteReceivableMember hcsg:FinancialAsset91To180DaysPastDueMember 2020-09-30 0000731012 hcsg:StandardNoteReceivableMember hcsg:FinancialAssetEqualToOrGreaterThan181DaysPastDueMember 2020-09-30 0000731012 hcsg:FinancialAsset0To90DaysPastDueMember hcsg:ElevatedRiskNoteReceivableMember 2020-09-30 0000731012 hcsg:ElevatedRiskNoteReceivableMember hcsg:FinancialAsset91To180DaysPastDueMember 2020-09-30 0000731012 hcsg:FinancialAssetEqualToOrGreaterThan181DaysPastDueMember hcsg:ElevatedRiskNoteReceivableMember 2020-09-30 0000731012 hcsg:FinancialAsset0To90DaysPastDueMember 2020-09-30 0000731012 hcsg:FinancialAsset91To180DaysPastDueMember 2020-09-30 0000731012 hcsg:FinancialAssetEqualToOrGreaterThan181DaysPastDueMember 2020-09-30 0000731012 hcsg:StandardNoteReceivableMember 2020-06-30 0000731012 hcsg:StandardNoteReceivableMember 2020-07-01 2020-09-30 0000731012 hcsg:ElevatedRiskNoteReceivableMember 2020-06-30 0000731012 hcsg:ElevatedRiskNoteReceivableMember 2020-07-01 2020-09-30 0000731012 hcsg:StandardNoteReceivableMember 2019-12-31 0000731012 hcsg:StandardNoteReceivableMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 0000731012 hcsg:StandardNoteReceivableMember 2020-01-01 2020-09-30 0000731012 hcsg:ElevatedRiskNoteReceivableMember 2019-12-31 0000731012 hcsg:ElevatedRiskNoteReceivableMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-01-01 0000731012 hcsg:ElevatedRiskNoteReceivableMember 2020-01-01 2020-09-30 0000731012 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-07-01 2020-09-30 0000731012 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-07-01 2019-09-30 0000731012 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-09-30 0000731012 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-09-30 0000731012 hcsg:HousekeepingAndDietaryEquipmentMember 2020-09-30 0000731012 hcsg:HousekeepingAndDietaryEquipmentMember 2019-12-31 0000731012 hcsg:ComputerHardwareAndSoftwareMember 2020-09-30 0000731012 hcsg:ComputerHardwareAndSoftwareMember 2019-12-31 0000731012 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2020-09-30 0000731012 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2019-12-31 0000731012 srt:MinimumMember 2020-09-30 0000731012 srt:MaximumMember 2020-09-30 0000731012 us-gaap:CustomerRelationshipsMember 2020-01-01 2020-09-30 0000731012 us-gaap:MunicipalBondsMember 2020-07-01 2020-09-30 0000731012 us-gaap:MunicipalBondsMember 2019-07-01 2019-09-30 0000731012 us-gaap:MunicipalBondsMember 2020-01-01 2020-09-30 0000731012 us-gaap:MunicipalBondsMember 2019-01-01 2019-09-30 0000731012 us-gaap:MunicipalBondsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0000731012 us-gaap:MunicipalBondsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000731012 us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel1Member 2020-09-30 0000731012 us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0000731012 us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:MoneyMarketFundsMember 2020-09-30 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:MoneyMarketFundsMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel2Member us-gaap:MoneyMarketFundsMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel3Member us-gaap:MoneyMarketFundsMember 2020-09-30 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember hcsg:BalancedAndLifestyleMember 2020-09-30 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember hcsg:BalancedAndLifestyleMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel1Member hcsg:BalancedAndLifestyleMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel2Member hcsg:BalancedAndLifestyleMember 2020-09-30 0000731012 hcsg:BalancedAndLifestyleMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0000731012 hcsg:LargeCapGrowthMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0000731012 hcsg:LargeCapGrowthMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000731012 hcsg:LargeCapGrowthMember us-gaap:FairValueInputsLevel1Member 2020-09-30 0000731012 hcsg:LargeCapGrowthMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0000731012 hcsg:LargeCapGrowthMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember hcsg:SmallCapGrowthMember 2020-09-30 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember hcsg:SmallCapGrowthMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel1Member hcsg:SmallCapGrowthMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel2Member hcsg:SmallCapGrowthMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel3Member hcsg:SmallCapGrowthMember 2020-09-30 0000731012 us-gaap:FixedIncomeInvestmentsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0000731012 us-gaap:FixedIncomeInvestmentsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000731012 us-gaap:FixedIncomeInvestmentsMember us-gaap:FairValueInputsLevel1Member 2020-09-30 0000731012 us-gaap:FixedIncomeInvestmentsMember us-gaap:FairValueInputsLevel2Member 2020-09-30 0000731012 us-gaap:FixedIncomeInvestmentsMember us-gaap:FairValueInputsLevel3Member 2020-09-30 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember hcsg:InternationalMember 2020-09-30 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember hcsg:InternationalMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel1Member hcsg:InternationalMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel2Member hcsg:InternationalMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel3Member hcsg:InternationalMember 2020-09-30 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember hcsg:MidCapGrowthMember 2020-09-30 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember hcsg:MidCapGrowthMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel1Member hcsg:MidCapGrowthMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel2Member hcsg:MidCapGrowthMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel3Member hcsg:MidCapGrowthMember 2020-09-30 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-09-30 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-09-30 0000731012 us-gaap:FairValueInputsLevel1Member 2020-09-30 0000731012 us-gaap:FairValueInputsLevel2Member 2020-09-30 0000731012 us-gaap:FairValueInputsLevel3Member 2020-09-30 0000731012 us-gaap:MunicipalBondsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000731012 us-gaap:MunicipalBondsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000731012 us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0000731012 us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000731012 us-gaap:MunicipalBondsMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:MoneyMarketFundsMember 2019-12-31 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:MoneyMarketFundsMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel2Member us-gaap:MoneyMarketFundsMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel3Member us-gaap:MoneyMarketFundsMember 2019-12-31 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember hcsg:BalancedAndLifestyleMember 2019-12-31 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember hcsg:BalancedAndLifestyleMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel1Member hcsg:BalancedAndLifestyleMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel2Member hcsg:BalancedAndLifestyleMember 2019-12-31 0000731012 hcsg:BalancedAndLifestyleMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000731012 hcsg:LargeCapGrowthMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000731012 hcsg:LargeCapGrowthMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000731012 hcsg:LargeCapGrowthMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0000731012 hcsg:LargeCapGrowthMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000731012 hcsg:LargeCapGrowthMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember hcsg:SmallCapGrowthMember 2019-12-31 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember hcsg:SmallCapGrowthMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel1Member hcsg:SmallCapGrowthMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel2Member hcsg:SmallCapGrowthMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel3Member hcsg:SmallCapGrowthMember 2019-12-31 0000731012 us-gaap:FixedIncomeInvestmentsMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000731012 us-gaap:FixedIncomeInvestmentsMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000731012 us-gaap:FixedIncomeInvestmentsMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0000731012 us-gaap:FixedIncomeInvestmentsMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000731012 us-gaap:FixedIncomeInvestmentsMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember hcsg:InternationalMember 2019-12-31 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember hcsg:InternationalMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel1Member hcsg:InternationalMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel2Member hcsg:InternationalMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel3Member hcsg:InternationalMember 2019-12-31 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember hcsg:MidCapGrowthMember 2019-12-31 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember hcsg:MidCapGrowthMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel1Member hcsg:MidCapGrowthMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel2Member hcsg:MidCapGrowthMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel3Member hcsg:MidCapGrowthMember 2019-12-31 0000731012 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000731012 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000731012 us-gaap:FairValueInputsLevel1Member 2019-12-31 0000731012 us-gaap:FairValueInputsLevel2Member 2019-12-31 0000731012 us-gaap:FairValueInputsLevel3Member 2019-12-31 0000731012 us-gaap:MunicipalBondsMember 2020-09-30 0000731012 us-gaap:MunicipalBondsMember 2019-12-31 0000731012 us-gaap:MunicipalBondsMember 2019-01-01 2019-12-31 0000731012 us-gaap:StockOptionMember 2020-01-01 2020-09-30 0000731012 us-gaap:StockOptionMember 2019-01-01 2019-09-30 0000731012 hcsg:RestrictedStockAndRestrictedStockUnitsRSUsMember 2020-01-01 2020-09-30 0000731012 hcsg:RestrictedStockAndRestrictedStockUnitsRSUsMember 2019-01-01 2019-09-30 0000731012 us-gaap:EmployeeStockMember 2020-01-01 2020-09-30 0000731012 us-gaap:EmployeeStockMember 2019-01-01 2019-09-30 0000731012 hcsg:A2020OmnibusIncentivePlanMember 2020-09-30 0000731012 hcsg:A2020OmnibusIncentivePlanMember 2020-01-01 2020-09-30 0000731012 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-09-30 0000731012 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0000731012 us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0000731012 us-gaap:RestrictedStockMember 2019-01-01 2019-09-30 0000731012 hcsg:RestrictedStockAndRestrictedStockUnitsRSUsMember 2019-12-31 0000731012 hcsg:RestrictedStockAndRestrictedStockUnitsRSUsMember 2020-09-30 0000731012 us-gaap:EmployeeStockMember 2020-09-30 0000731012 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2020-09-30 0000731012 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2020-01-01 2020-09-30 0000731012 us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2019-01-01 2019-09-30 0000731012 us-gaap:SubsequentEventMember 2020-10-21 2020-10-21 0000731012 hcsg:HousekeepingServicesMember 2020-07-01 2020-09-30 0000731012 hcsg:HousekeepingServicesMember 2019-07-01 2019-09-30 0000731012 hcsg:DietaryServicesMember 2020-07-01 2020-09-30 0000731012 hcsg:DietaryServicesMember 2019-07-01 2019-09-30 0000731012 us-gaap:OperatingSegmentsMember hcsg:HousekeepingServicesMember 2020-07-01 2020-09-30 0000731012 us-gaap:OperatingSegmentsMember hcsg:HousekeepingServicesMember 2019-07-01 2019-09-30 0000731012 us-gaap:OperatingSegmentsMember hcsg:HousekeepingServicesMember 2020-01-01 2020-09-30 0000731012 us-gaap:OperatingSegmentsMember hcsg:HousekeepingServicesMember 2019-01-01 2019-09-30 0000731012 us-gaap:OperatingSegmentsMember hcsg:DietaryServicesMember 2020-07-01 2020-09-30 0000731012 us-gaap:OperatingSegmentsMember hcsg:DietaryServicesMember 2019-07-01 2019-09-30 0000731012 us-gaap:OperatingSegmentsMember hcsg:DietaryServicesMember 2020-01-01 2020-09-30 0000731012 us-gaap:OperatingSegmentsMember hcsg:DietaryServicesMember 2019-01-01 2019-09-30 0000731012 hcsg:CorporateAndEliminationsMember 2020-07-01 2020-09-30 0000731012 hcsg:CorporateAndEliminationsMember 2019-07-01 2019-09-30 0000731012 hcsg:CorporateAndEliminationsMember 2020-01-01 2020-09-30 0000731012 hcsg:CorporateAndEliminationsMember 2019-01-01 2019-09-30 0000731012 us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-09-30 0000731012 hcsg:PrimeRateOrOvernightBankFundingRateMember 2020-01-01 2020-09-30 0000731012 us-gaap:LetterOfCreditMember 2020-09-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q
(Mark One)

| ☑ |  | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

For the quarterly period ended September 30, 2020
OR

| ☐ |  | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

For the transition period from to
Commission file number: 0-12015

HEALTHCARE SERVICES GROUP, INC.
(Exact name of registrant as specified in its charter)

Pennsylvania |  | 23-2018365
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)

3220 Tillman Drive, Suite 300, Bensalem, Pennsylvania
(Address of principal executive office)
19020
(Zip Code)
Registrant’s telephone number, including area code:
(215) 639-4274
Former name, former address and former ﬁscal year, if changed since last report:
Not Applicable
Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, $.01 par value | HCSG | NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

| Large accelerated filer | þ |  | Accelerated filer | ☐ |  |  |
| Non-accelerated filer | ☐ |  | Smaller reporting company | ☐ |  |  |
| Emerging growth company | ☐ |  |  |  |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No þ
Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. Common Stock, $.01 par value: 74,424,000 shares outstanding as of October 22, 2020.

Healthcare Services Group, Inc.
Quarterly Report on Form 10-Q
For the Period Ended September 30, 2020
TABLE OF CONTENTS

|  | Page
PART I |  |
Item 1. | Financial Statements (Unaudited) | 1
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 28
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 39
Item 4. | Controls and Procedures | 40
PART II |  |
Item 1. | Legal Proceedings | 41
Item 1A. | Risk Factors | 41
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 42
Item 3. | Defaults Upon Senior Securities | 42
Item 4. | Mine Safety Disclosures | 42
Item 5. | Other Information | 42
Item 6. | Exhibits | 43
SIGNATURES |  | 44

Table of Contents
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This report and documents incorporated by reference into it may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “will,” “goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services exclusively to the healthcare industry, primarily providers of long-term care; the impact of and future effects of the COVID-19 pandemic or other potential pandemics; having a significant portion of our consolidated revenues contributed by one customer during the nine months ended September 30, 2020; credit and collection risks associated with the healthcare industry; our claims experience related to workers’ compensation and general liability insurance (including any litigation claims, enforcement actions, regulatory actions and investigations arising from personal injury and loss of life related to COVID-19); the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company’s expectations with respect to selling, general, and administrative expense; continued realization of tax benefits arising from our corporate reorganization and self-funded health insurance program; the impact of the Securities and Exchange Commission investigation and related class action lawsuit; risks associated with the reorganization of our corporate structure; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2019 and under Item IA. “Risk Factors” in such Form 10-K and this Form 10-Q.
These factors, in addition to delays in payments from customers and/or customers in bankruptcy, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected if unexpected increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs and COVID-19) could not be passed on to our customers.
In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies.

Table of Contents
PART I — FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Healthcare Services Group, Inc.
Consolidated Balance Sheets
(in thousands, except per share amounts)
(Unaudited)

| September 30, 2020 |  | December 31, 2019
ASSETS: |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 109,920 |  |  | $ | 27,329 |
Marketable securities, at fair value | 94,042 |  |  | 90,711 |
Accounts and notes receivable, less allowance for doubtful accounts of $76,751 and $45,726 as of September 30, 2020 and December 31, 2019, respectively | 277,031 |  |  | 340,930 |
Inventories and supplies | 32,692 |  |  | 36,517 |
Prepaid expenses and other assets | 23,834 |  |  | 20,245 |
Total current assets | 537,519 |  |  | 515,732 |
Property and equipment, net | 27,807 |  |  | 28,820 |
Goodwill | 51,084 |  |  | 51,084 |
Other intangible assets, less accumulated amortization of $22,424 and $19,300 as of September 30, 2020 and December 31, 2019, respectively | 19,229 |  |  | 22,353 |
Notes receivable — long–term portion, less allowance for doubtful accounts of $5,342 and $6,667 as of September 30, 2020 and December 31, 2019, respectively | 39,458 |  |  | 46,992 |
Deferred compensation funding, at fair value | 40,969 |  |  | 37,247 |
Deferred income taxes | 38,265 |  |  | 20,364 |
Total assets | $ | 754,331 |  |  | $ | 722,592 |
LIABILITIES AND STOCKHOLDERS’ EQUITY: |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 53,940 |  |  | $ | 54,418 |
Accrued payroll and related taxes | 16,443 |  |  | 36,413 |
Other accrued expenses | 12,642 |  |  | 16,489 |
Borrowings under line of credit | — |  |  | 10,000 |
Income taxes payable | 25,495 |  |  | 8,075 |
Accrued insurance claims | 25,776 |  |  | 23,256 |
Total current liabilities | 134,296 |  |  | 148,651 |
Accrued insurance claims — long-term portion | 70,296 |  |  | 64,366 |
Deferred compensation liability | 41,045 |  |  | 37,621 |
Accrued payroll and related taxes - noncurrent | 32,304 |  |  | — |
Lease liability — long-term portion | 11,640 |  |  | 11,649 |
Commitments and contingencies (Note 15) |  |  |
STOCKHOLDERS’ EQUITY: |  |  |
Common stock, $0.01 par value; 100,000 shares authorized; 75,734 and 75,557 shares issued, and 74,423 and 74,149 shares outstanding as of September 30, 2020 and December 31, 2019, respectively | 757 |  |  | 756 |
Additional paid-in capital | 279,408 |  |  | 270,614 |
Retained earnings | 188,578 |  |  | 195,455 |
Accumulated other comprehensive income, net of taxes | 4,915 |  |  | 2,919 |
Common stock in treasury, at cost, 1,311 and 1,408 shares as of September 30, 2020 and December 31, 2019, respectively | (8,908) |  |  | (9,439) |
Total stockholders’ equity | 464,750 |  |  | 460,305 |
Total liabilities and stockholders’ equity | $ | 754,331 |  |  | $ | 722,592 |

See accompanying notes to consolidated financial statements.
1

Table of Contents
Healthcare Services Group, Inc.
Consolidated Statements of Comprehensive Income
(in thousands, except per share amounts)
(Unaudited)

| Three Months Ended September 30, |  |  |  | Nine Months Ended September 30, |  |
| 2020 |  | 2019 |  | 2020 |  | 2019
Revenues | $ | 435,947 |  |  | $ | 455,606 |  |  | $ | 1,337,126 |  |  | $ | 1,393,818 |
Operating costs and expenses: |  |  |  |  |  |  |
Costs of services provided | 365,443 |  |  | 398,404 |  |  | 1,140,116 |  |  | 1,226,154 |
Selling, general and administrative expense | 37,337 |  |  | 33,479 |  |  | 108,819 |  |  | 113,189 |
Other income (expense): |  |  |  |  |  |  |
Investment and other income, net | 4,279 |  |  | 733 |  |  | 7,197 |  |  | 7,329 |
Interest expense | (314) |  |  | (740) |  |  | (1,062) |  |  | (2,579) |
Income before income taxes | 37,132 |  |  | 23,716 |  |  | 94,326 |  |  | 59,225 |
Income tax provision | 9,488 |  |  | 5,372 |  |  | 23,391 |  |  | 13,539 |
Net income | $ | 27,644 |  |  | $ | 18,344 |  |  | $ | 70,935 |  |  | $ | 45,686 |
Per share data: |  |  |  |  |  |  |
Basic earnings per common share | $ | 0.37 |  |  | $ | 0.25 |  |  | $ | 0.95 |  |  | $ | 0.61 |
Diluted earnings per common share | $ | 0.37 |  |  | $ | 0.25 |  |  | $ | 0.95 |  |  | $ | 0.61 |
Weighted average number of common shares outstanding: |  |  |  |  |  |  |
Basic | 74,700 |  |  | 74,387 |  |  | 74,684 |  |  | 74,347 |
Diluted | 74,777 |  |  | 74,507 |  |  | 74,768 |  |  | 74,615 |
Comprehensive income: |  |  |  |  |  |  |
Net income | $ | 27,644 |  |  | $ | 18,344 |  |  | $ | 70,935 |  |  | $ | 45,686 |
Other comprehensive income: |  |  |  |  |  |  |
Unrealized gain on available-for-sale marketable securities, net of taxes | 873 |  |  | 457 |  |  | 1,996 |  |  | 2,664 |
Total comprehensive income | $ | 28,517 |  |  | $ | 18,801 |  |  | $ | 72,931 |  |  | $ | 48,350 |

See accompanying notes to consolidated financial statements.
2

Table of Contents
Healthcare Services Group, Inc.
Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)

| Nine Months Ended September 30, |  |
| 2020 |  | 2019
Cash flows from operating activities: |  |  |
Net income | $ | 70,935 |  |  | $ | 45,686 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
Depreciation and amortization | 10,752 |  |  | 10,397 |
Bad debt provision | 6,756 |  |  | 22,980 |
Deferred income tax (benefit) expense | (8,247) |  |  | 119 |
Share-based compensation expense | 5,917 |  |  | 5,468 |
Amortization of premium on marketable securities | 1,409 |  |  | 1,019 |
Unrealized gain on deferred compensation fund investments | (4,210) |  |  | (5,048) |
Changes in operating assets and liabilities: |  |  |
Accounts and notes receivable | 22,440 |  |  | (24,636) |
Inventories and supplies | 3,825 |  |  | 2,394 |
Prepaid expenses and other assets | (3,588) |  |  | 641 |
Deferred compensation funding | 488 |  |  | (223) |
Accounts payable and other accrued expenses | (9,104) |  |  | (9,420) |
Accrued payroll, accrued and withheld payroll taxes | 14,356 |  |  | 21,197 |
Income taxes payable | 17,420 |  |  | (4,074) |
Accrued insurance claims | 8,450 |  |  | 8,001 |
Deferred compensation liability | 3,950 |  |  | 5,721 |
Net cash provided by operating activities | 141,549 |  |  | 80,222 |
Cash flows from investing activities: |  |  |
Disposals of fixed assets | 475 |  |  | 127 |
Additions to property and equipment | (3,074) |  |  | (3,384) |
Purchases of marketable securities | (8,242) |  |  | (18,627) |
Sales of marketable securities | 5,979 |  |  | 17,628 |
Net cash used in investing activities | (4,862) |  |  | (4,256) |
Cash flows from financing activities: |  |  |
Dividends paid | (45,383) |  |  | (44,065) |
Reissuance of treasury stock pursuant to Dividend Reinvestment Plan | 69 |  |  | 67 |
Proceeds from the exercise of stock options | 1,893 |  |  | 3,166 |
Repayments of short-term borrowings | (10,000) |  |  | (20,000) |
Payments of statutory withholding on net issuance of restricted stock units | (675) |  |  | (587) |
Net cash used in financing activities | (54,096) |  |  | (61,419) |
Net change in cash and cash equivalents | 82,591 |  |  | 14,547 |
Cash and cash equivalents at beginning of the period | 27,329 |  |  | 26,025 |
Cash and cash equivalents at end of the period | $ | 109,920 |  |  | $ | 40,572 |

See accompanying notes to consolidated financial statements.
3

Table of Contents
Healthcare Services Group, Inc.
Consolidated Statements of Stockholders’ Equity
(in thousands)
(Unaudited)

| For the nine months ended September 30, 2020 |  |  |  |  |  |  |  |  |  |  |  |
| Common Stock |  |  |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive Income, net of taxes |  | Retained Earnings |  | Treasury Stock |  | Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |  |  |  |  |
Balance, December 31, 2019 | 75,557 |  |  | $ | 756 |  |  | $ | 270,614 |  |  | $ | 2,919 |  |  | $ | 195,455 |  |  | $ | (9,439) |  |  | $ | 460,305 |
Adjustment to adopt credit-loss guidance1 | — |  |  | — |  |  | — |  |  | — |  |  | (32,099) |  |  | — |  |  | (32,099) |
Balance, January 1, 2020 | 75,557 |  |  | $ | 756 |  |  | $ | 270,614 |  |  | $ | 2,919 |  |  | $ | 163,356 |  |  | $ | (9,439) |  |  | $ | 428,206 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |
Net income for the period | — |  |  | — |  |  | — |  |  | — |  |  | 20,190 |  |  | — |  |  | 20,190 |
Unrealized loss on available-for-sale marketable securities, net of taxes | — |  |  | — |  |  | — |  |  | (533) |  |  | — |  |  | — |  |  | (533) |
Comprehensive income for the period |  |  |  |  |  |  |  |  |  |  |  |  | $ | 19,657 |
Exercise of stock options and other share-based compensation, net of shares tendered for payment | 162 |  |  | 1 |  |  | 1,723 |  |  | — |  |  | — |  |  | — |  |  | 1,724 |
Payment of statutory withholding on issuance of restricted stock and restricted stock units | — |  |  | — |  |  | (661) |  |  | — |  |  | — |  |  | — |  |  | (661) |
Share-based compensation expense — stock options, restricted stock and restricted stock units | — |  |  | — |  |  | 1,822 |  |  | — |  |  | — |  |  | — |  |  | 1,822 |
Treasury shares issued for Deferred Compensation Plan funding and redemptions | — |  |  | — |  |  | 417 |  |  | — |  |  | — |  |  | 111 |  |  | 528 |
Shares issued pursuant to Employee Stock Plan | — |  |  | — |  |  | 1,329 |  |  | — |  |  | — |  |  | 506 |  |  | 1,835 |
Dividends paid and accrued, $0.20 per share | — |  |  | — |  |  | — |  |  | — |  |  | (15,142) |  |  | — |  |  | (15,142) |
Shares issued pursuant to Dividend Reinvestment Plan | — |  |  | — |  |  | 16 |  |  | — |  |  | — |  |  | 7 |  |  | 23 |
Other | 6 |  |  | — |  |  | 187 |  |  | — |  |  | — |  |  | — |  |  | 187 |
Balance, March 31, 2020 | 75,725 |  |  | $ | 757 |  |  | $ | 275,447 |  |  | $ | 2,386 |  |  | $ | 168,404 |  |  | $ | (8,815) |  |  | $ | 438,179 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |
Net income for the period | — |  |  | — |  |  | — |  |  | — |  |  | 23,101 |  |  | — |  |  | 23,101 |
Unrealized gain on available-for-sale marketable securities, net of taxes | — |  |  | — |  |  | — |  |  | 1,656 |  |  | — |  |  | — |  |  | 1,656 |
Comprehensive income for the period |  |  |  |  |  |  |  |  |  |  |  |  | $ | 24,757 |
Exercise of stock options and other share-based compensation, net of shares tendered for payment | 7 |  |  | — |  |  | 138 |  |  | — |  |  | — |  |  | — |  |  | 138 |
Share-based compensation expense — stock options, restricted stock and restricted stock units | — |  |  | — |  |  | 1,830 |  |  | — |  |  | — |  |  | — |  |  | 1,830 |
Treasury shares issued for Deferred Compensation Plan funding and redemptions | — |  |  | — |  |  | 51 |  |  | — |  |  | — |  |  | (53) |  |  | (2) |
Dividends paid and accrued, $0.20 per share | — |  |  | — |  |  | — |  |  | — |  |  | (15,237) |  |  | — |  |  | (15,237) |
Shares issued pursuant to Dividend Reinvestment Plan | — |  |  | — |  |  | 16 |  |  | — |  |  | — |  |  | 6 |  |  | 22 |
Balance, June 30, 2020 | 75,732 |  |  | $ | 757 |  |  | $ | 277,482 |  |  | $ | 4,042 |  |  | $ | 176,268 |  |  | $ | (8,862) |  |  | $ | 449,687 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |
Net income for the period | — |  |  | — |  |  | — |  |  | — |  |  | 27,644 |  |  | — |  |  | 27,644 |
Unrealized gain on available-for-sale marketable securities, net of taxes | — |  |  | — |  |  | — |  |  | 873 |  |  | — |  |  | — |  |  | 873 |
Comprehensive income for the period |  |  |  |  |  |  |  |  |  |  |  |  | $ | 28,517 |
Exercise of stock options and other share-based compensation, net of shares tendered for payment | 2 |  |  | — |  |  | 31 |  |  | — |  |  | — |  |  | — |  |  | 31 |
Payment of statutory withholding on issuance of restricted stock and restricted stock units | — |  |  | — |  |  | (14) |  |  | — |  |  | — |  |  | — |  |  | (14) |
Share-based compensation expense — stock options, restricted stock and restricted stock units | — |  |  | — |  |  | 1,840 |  |  | — |  |  | — |  |  | — |  |  | 1,840 |
Treasury shares issued for Deferred Compensation Plan funding and redemptions | — |  |  | — |  |  | 53 |  |  | — |  |  | — |  |  | (54) |  |  | (1) |
Dividends paid and accrued, $0.20 per share | — |  |  | — |  |  | — |  |  | — |  |  | (15,334) |  |  | — |  |  | (15,334) |
Shares issued pursuant to Dividend Reinvestment Plan | — |  |  | — |  |  | 16 |  |  | — |  |  | — |  |  | 8 |  |  | 24 |
Balance, September 30, 2020 | 75,734 |  |  | $ | 757 |  |  | $ | 279,408 |  |  | $ | 4,915 |  |  | $ | 188,578 |  |  | $ | (8,908) |  |  | $ | 464,750 |

1.See Note 4—Allowance for Doubtful Accounts regarding the new credit-loss guidance
See accompanying notes to consolidated financial statements.
4

Table of Contents

| For the nine months ended September 30, 2019 |  |  |  |  |  |  |  |  |  |  |  |
| Common Stock |  |  |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive Income, net of taxes |  | Retained Earnings |  | Treasury Stock |  | Stockholders’ Equity
| Shares |  | Amount |  |  |  |  |  |  |  |  |  |
Balance, December 31, 2018 | 75,344 |  |  | $ | 753 |  |  | $ | 259,440 |  |  | $ | 158 |  |  | $ | 190,092 |  |  | $ | (9,663) |  |  | $ | 440,780 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |
Net income for the period | — |  |  | — |  |  | — |  |  | — |  |  | 9,156 |  |  | — |  |  | 9,156 |
Unrealized gain on available-for-sale marketable securities, net of taxes | — |  |  | — |  |  | — |  |  | 1,416 |  |  | — |  |  | — |  |  | 1,416 |
Comprehensive income for the period |  |  |  |  |  |  |  |  |  |  |  |  | $ | 10,572 |
Exercise of stock options and other share-based compensation, net of shares tendered for payment | 115 |  |  | 2 |  |  | 1,911 |  |  | — |  |  | — |  |  | — |  |  | 1,913 |
Payment of statutory withholding on issuance of restricted stock and restricted stock units | — |  |  | — |  |  | (579) |  |  | — |  |  | — |  |  | — |  |  | (579) |
Share-based compensation expense — stock options, restricted stock and restricted stock units | — |  |  | — |  |  | 1,656 |  |  | — |  |  | — |  |  | — |  |  | 1,656 |
Treasury shares issued for Deferred Compensation Plan funding and redemptions | — |  |  | — |  |  | 535 |  |  | — |  |  | — |  |  | 1 |  |  | 536 |
Shares issued pursuant to Employee Stock Plan | — |  |  | — |  |  | 1,781 |  |  | — |  |  | — |  |  | 349 |  |  | 2,130 |
Dividends paid and accrued, $0.20 per share | — |  |  | — |  |  | — |  |  | — |  |  | (14,656) |  |  | — |  |  | (14,656) |
Shares issued pursuant to Dividend Reinvestment Plan | — |  |  | — |  |  | 18 |  |  | — |  |  | — |  |  | 5 |  |  | 23 |
Other | 6 |  |  | — |  |  | 174 |  |  | — |  |  | — |  |  | — |  |  | 174 |
Balance, March 31, 2019 | 75,465 |  |  | $ | 755 |  |  | $ | 264,936 |  |  | $ | 1,574 |  |  | $ | 184,592 |  |  | $ | (9,308) |  |  | $ | 442,549 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |
Net income for the period | — |  |  | — |  |  | — |  |  | — |  |  | 18,186 |  |  | — |  |  | 18,186 |
Unrealized gain on available-for-sale marketable securities, net of taxes | — |  |  | — |  |  | — |  |  | 791 |  |  | — |  |  | — |  |  | 791 |
Comprehensive income for the period |  |  |  |  |  |  |  |  |  |  |  |  | $ | 18,977 |
Exercise of stock options and other share-based compensation, net of shares tendered for payment | 54 |  |  | — |  |  | 1,186 |  |  | — |  |  | — |  |  | — |  |  | 1,186 |
Share-based compensation expense — stock options, restricted stock and restricted stock units | — |  |  | — |  |  | 1,668 |  |  | — |  |  | — |  |  | — |  |  | 1,668 |
Treasury shares issued for Deferred Compensation Plan funding and redemptions | — |  |  | — |  |  | 45 |  |  | — |  |  | — |  |  | (47) |  |  | (2) |
Dividends paid and accrued, $0.20 per share | — |  |  | — |  |  | — |  |  | — |  |  | (14,753) |  |  | — |  |  | (14,753) |
Shares issued pursuant to Dividend Reinvestment Plan | — |  |  | — |  |  | 18 |  |  | — |  |  | — |  |  | 5 |  |  | 23 |
Balance, June 30, 2019 | 75,519 |  |  | $ | 755 |  |  | $ | 267,853 |  |  | $ | 2,365 |  |  | $ | 188,025 |  |  | $ | (9,350) |  |  | $ | 449,648 |
Comprehensive income: |  |  |  |  |  |  |  |  |  |  |  |  |
Net income for the period | — |  |  | — |  |  | — |  |  | — |  |  | 18,344 |  |  | — |  |  | 18,344 |
Unrealized gain on available-for-sale marketable securities, net of taxes | — |  |  | — |  |  | — |  |  | 457 |  |  | — |  |  | — |  |  | 457 |
Comprehensive income for the period |  |  |  |  |  |  |  |  |  |  |  |  | $ | 18,801 |
Exercise of stock options and other share-based compensation, net of shares tendered for payment | 5 |  |  | — |  |  | 67 |  |  | — |  |  | — |  |  | — |  |  | 67 |
Payment of statutory withholding on issuance of restricted stock and restricted stock units | — |  |  | — |  |  | (8) |  |  | — |  |  | — |  |  | — |  |  | (8) |
Share-based compensation expense — stock options, restricted stock and restricted stock units | — |  |  | — |  |  | 1,626 |  |  | — |  |  | — |  |  | — |  |  | 1,626 |
Treasury shares issued for Deferred Compensation Plan funding and redemptions | — |  |  | — |  |  | 45 |  |  | — |  |  | — |  |  | (47) |  |  | (2) |
Dividends paid and accrued, 0.20 per share | — |  |  | — |  |  | — |  |  | — |  |  | (14,854) |  |  | — |  |  | (14,854) |
Shares issued pursuant to Dividend Reinvestment Plan | — |  |  | — |  |  | 15 |  |  | — |  |  | — |  |  | 6 |  |  | 21 |
Balance, September 30, 2019 | 75,524 |  |  | $ | 755 |  |  | $ | 269,598 |  |  | $ | 2,822 |  |  | $ | 191,515 |  |  | $ | (9,391) |  |  | $ | 455,299 |

See accompanying notes to consolidated financial statements.
5

Table of Contents
Healthcare Services Group, Inc.
Notes to Consolidated Financial Statements
(Unaudited)
Note 1—Description of Business and Significant Accounting Policies
Nature of Operations
Healthcare Services Group, Inc. (the “Company”) provides management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. Although the Company does not directly participate in any government reimbursement programs, the Company’s customers receive government reimbursements related to Medicare and Medicaid. Therefore, they are directly affected by any legislation relating to Medicare and Medicaid reimbursement programs.
The Company provides services primarily pursuant to full service agreements with its customers. In such agreements, the Company is responsible for the day-to-day management of employees located at the customers’ facilities. The Company also provides services on the basis of management-only agreements for a limited number of customers. The agreements with customers typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.
The Company is organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”).
Housekeeping consists of managing the customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of a customer’s facility, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at a customer facility.
Dietary consists of managing the customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and dietitian professional services, which includes the development of menus that meet residents’ dietary needs.
Unaudited Interim Financial Data
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and the requirements of Form 10-Q and Article 10 of Regulation S-X. Accordingly, these consolidated financial statements do not include all of the information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows. However, in the Company’s opinion, all adjustments which are of a normal recurring nature and are necessary for a fair presentation have been reflected in these consolidated financial statements. The balance sheet shown in this report as of December 31, 2019 has been derived from the audited financial statements for the year ended December 31, 2019. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The results of operations for the nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for any future period.
Use of Estimates in Financial Statements
In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of Healthcare Services Group, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.
6

Table of Contents
Cash and Cash Equivalents
Cash and cash equivalents are held in U.S. financial institutions or in custodial accounts with U.S. financial institutions. Cash equivalents are defined as short-term, highly liquid investments with a maturity of three months or less at time of purchase that are readily convertible into cash and have insignificant interest rate risk.
Accounts and Notes Receivable
Accounts and notes receivable consist of Housekeeping and Dietary segment trade receivables from contracts with customers. The Company’s payment terms with customers for services provided are defined within each customer’s service agreement. All accounts receivables are considered short term assets as the Company does not grant payment terms greater than one year. Accounts receivable initially are recorded at the transaction amount, and are recorded after the Company has an unconditional right to payment where only the passage of time is required before payment is received. Each reporting period, the Company evaluates the collectability of outstanding receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss. Additions to the allowance for doubtful accounts are made by recording a charge to bad debt expense reported in costs of services provided.
Notes receivable are initially recorded when accounts receivable are transferred into a promissory note and are recorded as an alternative to accounts receivable to memorialize an unqualified promise to pay a specific sum, typically with interest, in accordance with a defined payment schedule. The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however typically promissory notes mature over a 1 to 3 year period. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss.
Refer to Note 3—Accounts and Notes Receivable herein for further information.
Allowance for Doubtful Accounts
The guidance under the Financial Accounting Standards Board ("FASB") Accounting Standards Codification subtopic 326 Credit Losses - Measurement of Credit Losses on Financial Instruments ("ASC 326") became effective and was adopted by the Company prospectively as of January 1, 2020. In adopting ASC 326, the Company replaced its previous incurred loss impairment model for estimating credit losses on accounts and notes receivables for its reporting of quarterly and annual financial results with an expected loss model prepared in accordance with ASC 326. While the incurred loss impairment model had the Company recognize credit losses when it was probable that a loss had been incurred, ASC 326 requires the Company to estimate the lifetime expected credit losses on such instruments and to record an allowance to offset the receivables. ASC 326 requires the recognition of credit losses that are expected based on existing accounts and notes receivable as compared to the incurred loss approach. Accordingly, credit losses under ASC 326 generally are recognized earlier in the life cycle of a receivable than under the Company’s previous incurred loss model. Modeling must be prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses. Under the previous incurred loss impairment model, credit losses were recognized when Management determined that it was more likely than not that a loss had been incurred and such loss was estimable.
Refer to Note 4—Allowance for Doubtful Accounts herein for further information.
7

Table of Contents
The cumulative effect of initially applying the new ASC 326 guidance to the consolidated financial statements on January 1, 2020 was as follows:

Consolidated Statement of Financial Position |  | December 31, 2019 |  | Cumulative Impact from Adopting ASC 326 Guidance |  | January 1, 2020
|  | (in thousands) |  |  |  |
Assets |  |  |  |  |  |
Short-term accounts and notes receivable, less allowance for doubtful accounts |  | $ | 340,930 |  |  | $ | (41,100) |  |  | $ | 299,830 |
Notes receivable – long–term portion, less allowance for doubtful accounts |  | $ | 46,992 |  |  | $ | (1,136) |  |  | $ | 45,856 |
Allowance for doubtful accounts on short-term accounts and notes receivables |  | $ | (45,726) |  |  | $ | (41,100) |  |  | $ | (86,826) |
Allowance for doubtful accounts on long-term notes receivables |  | $ | (6,667) |  |  | $ | (1,136) |  |  | $ | (7,803) |
Deferred income taxes |  | $ | 20,364 |  |  | $ | 10,137 |  |  | $ | 30,501 |
Stockholders’ equity |  |  |  |  |  |
Retained earnings |  | $ | 195,455 |  |  | $ | (32,099) |  |  | $ | 163,356 |

Inventories and Supplies
Inventories and supplies include housekeeping, linen and laundry supplies, as well as food provisions and supplies. Non-linen inventories and supplies are stated on a first-in, first-out (FIFO) basis, and reduced as deemed necessary to approximate the lower of cost or net realizable value. Linen supplies are amortized on a straight-line basis over their estimated useful life of 24 months.
Revenue Recognition
The Company recognizes revenue from contracts with customers when or as the promised goods and services are provided to customers. Revenues are reported net of sales taxes that are collected from customers and remitted to taxing authorities.
The guidance under the FASB Accounting Standards Codification subtopic 606 Revenue from Contracts with Customers ("ASC 606") requires the Company to recognize revenue as the promised goods and services within the terms of the Company’s contracts are performed and satisfied. The amount of revenue recognized by the Company is based on the consideration to which the Company is entitled in exchange for providing the contracted goods and services. Refer to Note 2—Revenue herein for further information.
Leases
The guidance under FASB Accounting Standards Codification subtopic ASC 842 Leases (“ASC 842”) became effective and was adopted by the Company as of January 1, 2019, by applying a modified retrospective transition approach which resulted in the capitalization of the Company’s existing operating leases as of January 1, 2019. As such, the Company records assets and liabilities on the balance sheet to recognize the rights and obligations arising from leasing arrangements with contractual terms greater than 12 months, as permitted by U.S. GAAP. A leasing arrangement includes any contract which entitles the Company to the right of use of an identified tangible asset where there are no restrictions as to the direct of use of the asset, and the Company obtains substantially all of the economic benefits from the right of use. As of September 30, 2020 and December 31, 2019, the Company was only the lessee of operating lease arrangements.
Refer to Note 7—Leases herein for further information.
Income Taxes
The Company uses the asset and liability method of accounting for income taxes. Under this method, income tax expense or benefits are recognized for the amount of taxes payable or refundable for the current period. The Company accrues for probable tax obligations as required, based on facts and circumstances in various regulatory environments. In addition, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. When appropriate, valuation allowances are recorded to reduce deferred tax assets to amounts for which realization is more likely than not.
8

Table of Contents
Uncertain income tax positions taken or expected to be taken in tax returns are reflected within the Company’s financial statements based on a recognition and measurement process.
Earnings per Common Share
Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is computed using the weighted-average number of common shares outstanding and dilutive common shares, such as those issuable upon exercise of stock options and upon the vesting of restricted stock and restricted stock units.
Share-Based Compensation
The Company estimates the fair value of share-based awards on the date of grant using the Black-Scholes valuation model for stock options and using the share price on the date of grant for restricted stock and restricted stock units. The value of the award is recognized ratably as an expense in the Company’s Consolidated Statements of Comprehensive Income over the requisite service periods, with adjustments made for forfeitures as they occur.
Identifiable Intangible Assets and Goodwill
Identifiable intangible assets are amortized on a straight-line basis over their respective lives. Goodwill represents the excess of cost over the fair value of net assets of acquired businesses. Management reviews the carrying value of goodwill annually during the fourth quarter to assess for impairment, or more often if events or circumstances indicate that the carrying value may exceed its estimated fair value.
No impairment loss was recognized on the Company's intangible assets or goodwill during the nine months ended September 30, 2020 or 2019.
Concentrations of Credit Risk
The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At September 30, 2020 and December 31, 2019, substantially all of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets.
The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. As a result, the Company may not realize the full effects of such programs until these laws are fully implemented and governmental agencies issue applicable regulations or guidance.
Note 2—Revenue
The Company presents its consolidated revenues disaggregated by reportable segment, as Management evaluates the nature, amount, timing and uncertainty of the Company’s revenues by segment. Refer to Note 13—Segment Information herein as well as the information below regarding the Company’s reportable segments.
9

Table of Contents
Housekeeping
Housekeeping accounted for $675.4 million and $687.4 million of the Company’s consolidated revenues for the nine months ended September 30, 2020 and 2019, respectively, which represented approximately 50.5% and 49.3% of the Company’s revenues in each respective period. The Housekeeping services include managing customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the customers’ facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the customers’ facilities. Upon beginning service with a customer facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate housekeeping services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality-control procedures including continuous training and employee evaluation.
Dietary
Dietary services accounted for $661.8 million and $706.4 million of the Company’s consolidated revenues for the nine months ended September 30, 2020 and 2019, respectively, which represented approximately 49.5% and 50.7% of the Company’s revenues in each respective period. Dietary services consist of managing customers’ dietary departments which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. On-site management is responsible for all daily dietary department activities, with regular support provided by a District Manager specializing in dietary services. The Company also offers clinical consulting services to facilities which if contracted is a service bundled within the monthly service provided to customers. Upon beginning service with a customer facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate dietitian services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality-control procedures including continuous training and employee evaluation.
Revenue Recognition
All of the Company’s revenues are derived from contracts with customers. The Company accounts for revenue from contracts with customers in accordance with ASC 606, and as such, the Company recognizes revenue to depict the transfer of promised goods and services to customers in amounts that reflect the consideration to which the Company is entitled in exchange for those goods and services. The Company’s costs of obtaining contracts are not material.
The Company performs services and provides goods in accordance with its contracts with its customers. Such contracts typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice, after an initial period of 60 to 120 days. A performance obligation is the unit of account under ASC 606 and is defined as a promise in a contract to transfer a distinct good or service to the customer. The Company’s Housekeeping and Dietary contracts relate to the provision of bundles of goods, services or both, which represent a series of distinct goods and services that are substantially the same and that have the same pattern of transfer to the customer. The Company accounts for the series as a single performance obligation satisfied over time, as the customer simultaneously receives and consumes the benefits of the goods and services provided. Revenue is recognized using the output method, which is based upon the delivery of goods and services to the customers’ facilities. In limited cases, the Company provides goods, services or both, before the execution of a written contract. In these cases, the Company defers the recognition of revenue until a contract is executed. The amount of such deferred revenue was $0.4 million and $0.3 million as of September 30, 2020 and December 31, 2019, respectively. Additionally, substantially all such revenue amounts deferred as of December 31, 2019 were subsequently recognized as revenue during the nine months ended September 30, 2020.
The transaction price is the amount of consideration to which the Company is entitled in exchange for transferring promised goods or services to its customers. The transaction price does not include taxes assessed or collected. The Company’s contracts detail the fees that the Company charges for the goods and services it provides. For certain contracts which contain a variable component to the transaction price, the Company is required to make estimates of the amount of consideration to which the Company will be entitled, based on variability in resident and patient populations serviced, product usage or quantities consumed. The Company recognizes revenue related to such estimates only when the Company determines that there will not be a significant reversal in the amount of revenue recognized. The Company’s contracts generally do not contain significant financing components, as payment terms are less than one year.
10

Table of Contents
The Company allocates the transaction price to each performance obligation, noting that the bundle of goods, services or goods and services provided under each Housekeeping and Dietary contract represents a single performance obligation that is satisfied over time. The Company recognizes the related revenue when it satisfies the performance obligation by transferring a bundle of promised goods, services or both to a customer. Such recognition is on a monthly or weekly basis, as goods are provided and services are performed. In some cases, the Company requires customers to pay in advance for goods and services to be provided. As of September 30, 2020 and December 31, 2019, the value of the contract liabilities associated with customer prepayments was not material. Additionally, substantially all such revenue amounts deferred as of December 31, 2019 were subsequently recognized as revenue during the nine months ended September 30, 2020.
Transaction Price Allocated to Remaining Performance Obligations
The Company recognizes revenue as it satisfies the performance obligations associated with contracts with customers, which due to the nature of the goods and services provided by the Company, are satisfied over time. Contracts may contain transaction prices that are fixed, variable or both. The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.
At September 30, 2020, the Company had $521.4 million related to performance obligations that were unsatisfied or partially unsatisfied for which the Company expects to recognize revenue. The Company expects to recognize revenue on approximately 29.3% of the remaining performance obligations over the next 12 months, with the balance to be recognized thereafter. These amounts exclude variable consideration primarily related to performance obligations that consists of a series of distinct service periods with revenues based on future performance that cannot be estimated at contract inception. The Company also has elected to apply the practical expedient that permits exclusion of information about the remaining performance obligations with original expected durations of one year or less.
Note 3—Accounts and Notes Receivable
The Company’s accounts and notes receivable balances consisted of the following as of September 30, 2020 and December 31, 2019:

| September 30, 2020 |  | December 31, 2019
| (in thousands) |  |
Short-term |  |  |
Accounts and notes receivable | $ | 353,782 |  |  | $ | 386,656 |
Allowance for doubtful accounts1 | (76,751) |  |  | (45,726) |
Total net short-term accounts and notes receivable | $ | 277,031 |  |  | $ | 340,930 |
Long-term |  |  |
Notes receivable | $ | 44,800 |  |  | $ | 53,659 |
Allowance for doubtful accounts1 | (5,342) |  |  | (6,667) |
Total net long-term notes receivable | $ | 39,458 |  |  | $ | 46,992 |
Total net accounts and notes receivable | $ | 316,489 |  |  | $ | 387,922 |

1.Effective January 1, 2020, the Company adopted ASC 326 and recorded a one-time adoption adjustment of $42.2 million
The Company makes credit decisions on a case-by-case basis after reviewing a number of qualitative and quantitative factors related to the specific customer as well as current industry variables that may impact that customer. There are a variety of factors that impact a customer’s ability to pay in accordance with the Company’s contracts. These factors include, but are not limited to, fluctuating census numbers, litigation costs and the customer’s participation in programs funded by federal and state governmental agencies. Deviations in the timing or amounts of reimbursements under those programs can impact the customer’s cash flows and its ability to make timely payments. However, the customer’s obligation to pay the Company in accordance with the contracts are not contingent upon the customer’s cash flow. Notwithstanding the Company’s efforts to minimize its credit risk exposure, the aforementioned factors, as well as other factors that impact customer cash flows or ability to make timely payments, could have an indirect, yet material adverse effect on the Company’s results of operations and financial condition.
11

Table of Contents
Fluctuations in net accounts and notes receivable are generally attributable to a variety of factors including, but not limited to, the timing of cash receipts from customers and the inception, transition, modification or termination of customer relationships. The Company deploys significant resources and has invested in tools and processes to optimize Management’s credit and collections efforts. When appropriate, the Company utilizes interest-bearing promissory notes to enhance the collectability of amounts due, by instituting definitive repayment plans and providing a means by which to further evidence the amounts owed. In addition, the Company may amend contracts from full service to management-only arrangements, or adjust contractual payment terms, to accommodate customers who have in good faith established clearly-defined plans for addressing cash flow issues. These efforts are intended to minimize the Company’s collections risk.
Note 4 - Allowance for Doubtful Accounts
On January 1, 2020 (the "adoption date"), the Company replaced its previous incurred loss impairment model for estimating credit losses on accounts and notes receivables with an expected loss model prepared in accordance with ASC 326. While the incurred loss impairment model had the Company recognize credit losses when it was probable that a loss had been incurred, ASC 326 requires the Company to estimate future expected credit losses on such instruments before an impairment may occur. On the adoption date, the Company recorded an initial increase of $42.2 million to the Company's allowance for doubtful accounts, with an offset recorded as an opening adjustment to retained earnings.
In making the Company’s credit evaluations, management considers the general collection risk associated with trends in the long-term care industry. The Company establishes credit limits through payment terms with customers, performs ongoing credit evaluations and monitors accounts on an aging schedule basis to minimize the risk of loss. Despite the Company’s efforts to minimize credit risk exposure, customers could be adversely affected if future industry trends, including those related to COVID-19, change in such a manner as to negatively impact their cash flows. The full effects of COVID-19 on the Company’s customers are highly uncertain and cannot be predicted. As a result, the Company’s future collection experience can differ significantly from historical collection trends. If the Company’s customers experience a negative impact on their cash flows, it could have a material adverse effect on the Company’s results of operations and financial condition.
The Company evaluates its accounts and notes receivable for expected credit losses quarterly. Accounts receivables are evaluated based on internally developed credit quality indicators derived from the aging of receivables. Notes receivable are evaluated based on internally developed credit quality indicators derived from Management’s assessment of collection risk. The Company manages note receivable portfolios using a two tiered approach by disaggregating standard notes receivables, which are promissory notes in good standing, from those who have been identified by Management as having an elevated credit risk profile due to a trigger event such as bankruptcy. At the end of each period the Company sets a reserve for expected credit losses on standard notes receivable based on the Company’s historical loss rate. Notes receivable with an elevated risk profile, which are from customers who have filed bankruptcy, are subject to collections activity or are slow payers that are experiencing financial difficulties, are aggregated and evaluated to determine the total reserve for the class of receivable.
The guidance in ASC 326 permits entities to make an accounting policy election not to measure an estimate for credit losses on accrued interest if those entities write-off accrued interest deemed uncollectible in a timely manner. The Company follows an income recognition policy on all interest earned on notes receivable. Under such policy the Company accounts for all notes receivable on a non-accrual basis and defers the recognition of any interest income until receipt of cash payments. This policy was established, recognizing the environment of the long-term care industry, and not because such notes receivable are necessarily impaired. Accordingly, the Company does not record a credit loss adjustment for accrued interest. For the three and nine months ended September 30, 2020, the Company recognized $0.3 million and $1.3 million in interest income from notes receivables.
12

Table of Contents
As part of the Company’s adoption of ASC 326, there are additional disclosures required to be made on a class of financing receivable basis. The following table presents the Company’s two tiers of notes receivable further disaggregated by year of origination, as well as write-off activity for the current nine month period ending September 30, 2020:

|  | Notes Receivable |  |  |  |  |  |  |  |  |  |  |  |
|  | Amortized Cost Basis by Origination Year |  |  |  |  |  |  |  |  |  |  |  |
|  | 2020 |  | 2019 |  | 2018 |  | 2017 |  | 2016 |  | Prior |  | Total
|  | (in thousands) |  |  |  |  |  |  |  |  |  |  |  |
Notes Receivable |  |  |  |  |  |  |  |  |  |  |  |  |  |
Standard notes receivable |  | $ | 7,007 |  |  | $ | 11,716 |  |  | $ | 17,608 |  |  | $ | 26,260 |  |  | $ | 28 |  |  | $ | 1,598 |  |  | $ | 64,217 |
Elevated risk notes receivable |  | $ | — |  |  | $ | 603 |  |  | $ | — |  |  | $ | 5,511 |  |  | $ | — |  |  | $ | 2,421 |  |  | $ | 8,535 |
Current-period gross write-offs |  | $ | — |  |  | $ | — |  |  | $ | 411 |  |  | $ | — |  |  | $ | 1,970 |  |  | $ | 40 |  |  | $ | 2,421 |
Current-period recoveries |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Current-period net write-offs |  | $ | — |  |  | $ | — |  |  | $ | 411 |  |  | $ | — |  |  | $ | 1,970 |  |  | $ | 40 |  |  | $ | 2,421 |

The following table provides information as to the status of payment on the Company’s notes receivable which were past due as of September 30, 2020:

|  | Age Analysis of Past-Due Notes Receivable as of September 30, 2020 |  |  |  |  |  |
|  | 0-90 Days |  | 91 - 180 Days |  | Greater than 181 Days |  | Total
|  | (in thousands) |  |  |  |  |  |
Notes Receivable |  |  |  |  |  |  |  |
Standard notes receivable |  | $ | 3,979 |  |  | $ | 606 |  |  | $ | 3,425 |  |  | $ | 8,010 |
Elevated risk notes receivable |  | 613 |  |  | 1,035 |  |  | 6,864 |  |  | 8,512 |
|  | $ | 4,592 |  |  | $ | 1,641 |  |  | $ | 10,289 |  |  | $ | 16,522 |

13

Table of Contents
The following table provides a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the three and nine months ended September 30, 2020:

|  | Allowance for doubtful accounts |  |  |  |  |  |
Portfolio Segment: |  | June 30 2020 |  | Write-Offs1 |  | Bad Debt Expense |  | September 30 2020
|  | (in thousands) |  |  |  |  |  |
Accounts Receivables |  | $ | 66,299 |  |  | $ | (2,475) |  |  | $ | 967 |  |  | $ | 64,791 |
Notes Receivables |  |  |  |  |  |  |  |
Standard notes receivable |  | $ | 11,869 |  |  | $ | (253) |  |  | $ | (132) |  |  | $ | 11,484 |
Elevated risk notes receivable |  | 5,818 |  |  | — |  |  | — |  |  | 5,818 |
|  | $ | 17,687 |  |  | $ | (253) |  |  | $ | (132) |  |  | $ | 17,302 |
Total accounts and notes receivable |  | $ | 83,986 |  |  | $ | (2,728) |  |  | $ | 835 |  |  | $ | 82,093 |

1.Write-offs are shown net of recoveries. During the three months ended September 30, 2020, the Company collected $0.1 million of accounts receivables that were recovered subsequent to being written-off.

|  | Allowance for doubtful accounts |  |  |  |  |  |  |  |
Portfolio Segment: |  | December 31, 2019 |  | Cumulative effect of ASC 326 adoption1 |  | Write-Offs2 |  | Bad Debt Expense |  | September 30, 2020
|  | (in thousands) |  |  |  |  |  |  |  |
Accounts receivable |  | $ | 39,903 |  |  | $ | 36,709 |  |  | $ | (16,871) |  |  | $ | 5,050 |  |  | $ | 64,791 |
Notes receivable |  |  |  |  |  |  |  |  |  |
Standard notes receivable |  | $ | 6,667 |  |  | $ | 5,236 |  |  | $ | (1,974) |  |  | $ | 1,555 |  |  | $ | 11,484 |
Elevated risk notes receivable |  | 5,823 |  |  | 291 |  |  | (447) |  |  | 151 |  |  | 5,818 |
Total notes receivable |  | $ | 12,490 |  |  | $ | 5,527 |  |  | $ | (2,421) |  |  | $ | 1,706 |  |  | $ | 17,302 |
Total accounts and notes receivable |  | $ | 52,393 |  |  | $ | 42,236 |  |  | $ | (19,292) |  |  | $ | 6,756 |  |  | $ | 82,093 |

1.Represents the pre-tax one-time adjustment to the Company’s 2020 opening retained earnings balance in accordance with the adoption of the CECL accounting guidance.
2.Write-offs are shown net of recoveries. During the nine months ended September 30, 2020, the Company collected $0.9 million of accounts receivables that were recovered subsequent to being written-off.
14

Table of Contents
Note 5—Changes in Accumulated Other Comprehensive Income by Component
Accumulated other comprehensive income consists of unrealized gains and losses from the Company’s available-for-sale marketable securities. The following table provides a summary of the changes in accumulated other comprehensive income for the nine months ended September 30, 2020 and 2019:

| Unrealized Gains and Losses on Available-for-Sale Securities1 |  |
| Nine Months Ended September 30, |  |
| 2020 |  | 2019
| (in thousands) |  |
Accumulated other comprehensive income — beginning balance | $ | 2,919 |  |  | $ | 158 |
Other comprehensive income before reclassifications | 1,925 |  |  | 2,754 |
Losses (gains) reclassified from other comprehensive income2 | 71 |  |  | (90) |
Net current period other comprehensive income3 | 1,996 |  |  | 2,664 |
Accumulated other comprehensive income — ending balance | $ | 4,915 |  |  | $ | 2,822 |

1.All amounts are net of tax
2.Realized gains and losses were recorded pre-tax under “Investment and other income” in the Consolidated Statements of Comprehensive Income. For the nine months ended September 30, 2020, the Company recorded $0.1 million of realized losses from the sale of available-for-sale securities. For the nine months ended September 30, 2019, the Company recorded $0.1 million of realized gains from the sale of available-for-sale securities. Refer to Note 9—Fair Value Measurements herein for further information.
3.For the nine months ended September 30, 2020 and 2019, the changes in other comprehensive income were net of a tax expense of $0.5 million and $0.7 million, respectively.

| Amounts Reclassified from Accumulated Other Comprehensive Income |  |
| 2020 |  | 2019
| (in thousands) |  |
Three Months Ended September 30, |  |  |
(Losses) gains from the sale of available-for-sale securities | $ | (7) |  |  | $ | 14 |
Tax benefit (expense) | 2 |  |  | (3) |
Net (loss) gain reclassified from accumulated other comprehensive income | $ | (5) |  |  | $ | 11 |
Nine Months Ended September 30, |  |  |
(Losses) gains from the sale of available-for-sale securities | $ | (94) |  |  | $ | 117 |
Tax benefit (expense) | 23 |  |  | (27) |
Net (loss) gain reclassified from accumulated other comprehensive income | $ | (71) |  |  | $ | 90 |

15

Table of Contents
Note 6—Property and Equipment
Property and equipment are recorded at cost. Depreciation is recorded over the estimated useful life of each class of depreciable asset, and is computed using the straight-line method. Leasehold improvements are amortized over the shorter of the estimated asset life or term of the lease. Repairs and maintenance costs are charged to expense as incurred.
The following table sets forth the amounts of property and equipment by each class of depreciable asset as of September 30, 2020 and December 31, 2019:

| September 30, 2020 |  | December 31, 2019
| (in thousands) |  |
Housekeeping and dietary equipment | $ | 22,534 |  |  | $ | 25,219 |
Computer hardware and software | 9,494 |  |  | 12,769 |
Operating lease — right-of-use assets | 25,196 |  |  | 21,176 |
Other1 | 1,617 |  |  | 1,698 |
Total property and equipment, at cost | 58,841 |  |  | 60,862 |
Less accumulated depreciation | 31,034 |  |  | 32,042 |
Total property and equipment, net | $ | 27,807 |  |  | $ | 28,820 |

1.Includes furniture and fixtures, leasehold improvements and autos and trucks including auto leases.
Depreciation expense for the three months ended September 30, 2020 and 2019 was $2.5 million and $2.4 million, respectively. Depreciation expense for the nine months ended September 30, 2020 and 2019 was $7.6 million and $7.2 million, respectively. Of the depreciation expense recorded for the three and nine months ended September 30, 2020, $1.4 million and $4.2 million related to the depreciation of the Company’s operating lease - right-of-use assets ("ROU Assets"), respectively. Of the depreciation expense recorded for the three and nine months ended September 30, 2019, $1.3 million and $3.5 million related to the depreciation of the Company's operating lease - ROU Assets, respectively.
Note 7—Leases
The Company recognizes ROU Assets and lease liabilities (“Lease Liabilities”) for automobiles, office buildings, IT equipment, and small storage units for the temporary storage of operational equipment. The Company’s leases have remaining lease terms ranging from less than 1 year to 10 years, and have extension options ranging from 1 year to 5 years. Most leases include the option to terminate the lease within 1 year.
Upon adopting ASC 842, the Company made accounting policy elections using practical expedients offered under the guidance to combine lease and non-lease components within leasing arrangements and to recognize the payments associated with short-term leases in earnings on a straight-line basis over the lease term, with the cost associated with variable lease payments recognized when incurred. These accounting policy elections impact the value of the Company’s ROU Assets and Lease Liabilities. The value of the Company’s ROU Assets is determined as the non-depreciated fair value of its leasing arrangements and is recorded to Property and Equipment, net on the Company’s Consolidated Balance Sheets. The value of the Company’s Lease Liabilities is the present value of fixed lease payments not yet paid, discounted using either the rate implicit in the lease contract if that rate can be determined, or the Company’s incremental borrowing rate ("IBR") and is recorded in Other accrued expenses and Lease liability — long-term portion on the Company’s Consolidated Balance Sheets. Any future lease payments that are not fixed based on the terms of the lease contract, or fluctuate based on a factor other than an index or rate, are considered variable lease payments and are not included in the value of the Company’s ROU Assets or Lease Liabilities. The Company’s IBR is determined as the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment.
16

Table of Contents
Components of lease expense required by ASC 842 are presented below for the three and nine months ended September 30, 2020 and 2019.

|  | Three Months Ended September 30, |  |
|  | 2020 |  | 2019
|  | (in thousands) |  |
Lease cost |  |  |  |
Operating lease cost |  | $ | 1,404 |  |  | $ | 1,248 |
Short-term lease cost |  | 135 |  |  | 88 |
Variable lease cost |  | 188 |  |  | 150 |
Total lease cost |  | $ | 1,727 |  |  | $ | 1,486 |

|  | Nine Months Ended September 30, |  |
|  | 2020 |  | 2019
|  | (in thousands) |  |
Lease cost |  |  |  |
Operating lease cost |  | $ | 4,153 |  |  | $ | 3,478 |
Short-term lease cost |  | 388 |  |  | 649 |
Variable lease cost |  | 450 |  |  | 434 |
Total lease cost |  | $ | 4,991 |  |  | $ | 4,561 |

Supplemental information required by ASC 842 is presented below for the nine months ended September 30, 2020 and 2019.

|  | Nine Months Ended September 30, |  |
|  | 2020 |  | 2019
|  | (dollar amounts in thousands) |  |
Other information |  |  |  |
Cash paid for amounts included in the measurement of lease liabilities |  |  |  |
Operating cash flows from operating leases |  | $ | 4,218 |  |  | $ | 3,605 |
Weighted-average remaining lease term — operating leases |  | 5.6 years |  | 6.4 years
Weighted-average discount rate — operating leases |  | 4.6 | % |  | 4.8 | %

During the three and nine months ended September 30, 2020, the Company’s ROU Assets and Lease Liabilities were both reduced by $0.1 million and $0.3 million, respectively due to lease cancellations. During the three and nine months ended September 30, 2019, the Company’s ROU Assets and Lease Liabilities were both reduced by less than $0.1 million and $0.1 million, respectively due to lease cancellations.
17

Table of Contents
The following is a schedule by calendar year of future minimum lease payments under operating leases that have remaining terms as of September 30, 2020:

Period/Year |  | Operating Leases
|  | (in thousands)
October 1 to December 31, 2020 |  | $ | 1,473 |
2021 |  | 5,001 |
2022 |  | 3,820 |
2023 |  | 1,950 |
2024 |  | 1,295 |
2025 |  | 1,311 |
Thereafter |  | 4,204 |
Total minimum lease payments |  | $ | 19,054 |
Less: imputed lease discount |  | $ | 2,091 |
Present value of lease liabilities |  | $ | 16,963 |

Note 8—Other Intangible Assets
The Company’s other intangible assets consist of customer relationships which were obtained through acquisitions and are recorded at their fair values at the date of acquisition. Intangible assets with determinable lives are amortized on a straight-line basis over their estimated useful lives. The customer relationships have a weighted-average amortization period of approximately 10 years.
The following table sets forth the estimated amortization expense for intangibles subject to amortization for the remainder of 2020, the following five fiscal years and thereafter:

Period/Year |  | Total Amortization Expense
|  | (in thousands)
October 1 to December 31, 2020 |  | $ | 1,042 |
2021 |  | $ | 4,165 |
2022 |  | $ | 4,165 |
2023 |  | $ | 3,169 |
2024 |  | $ | 2,035 |
2025 |  | $ | 2,035 |
Thereafter |  | $ | 2,618 |

Amortization expense for both the three months ended September 30, 2020 and 2019 was $1.0 million. Amortization expense for both the nine months ended September 30, 2020 and 2019 was $3.1 million.
Note 9—Fair Value Measurements
The Company’s current assets and current liabilities are financial instruments and most of these items (other than marketable securities and inventories) are recorded at cost in the Consolidated Balance Sheets. The estimated fair value of these financial instruments approximates their carrying value due to their short-term nature. The carrying value of the Company’s line of credit represents the outstanding amount of the borrowings, which approximates fair value. The Company’s financial assets that are measured at fair value on a recurring basis are its marketable securities and deferred compensation funding. The recorded values of all of the financial instruments approximate their current fair values because of their nature, stated interest rates and respective maturity dates or durations.
18

Table of Contents
The Company’s marketable securities consist of tax-exempt municipal bonds, which are classified as available-for-sale and are reported at fair value. Unrealized gains and losses associated with these investments are included in other comprehensive income (net of tax) within the Consolidated Statements of Comprehensive Income. The fair value of these marketable securities is classified within Level 2 of the fair value hierarchy, as these securities are measured using quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable. Such valuations are determined by a third-party pricing service. For the three months ended September 30, 2020 and 2019, the Company recorded unrealized gains of $0.9 million and $0.5 million on marketable securities, respectively. For the nine months ended September 30, 2020 and 2019, the Company recorded unrealized gains of $2.0 million and $2.7 million on marketable securities, respectively.
For the three months ended September 30, 2020 and 2019, the Company received total proceeds, less the amount of interest received, of $0.2 million and $10.5 million, respectively, from sales of available-for-sale municipal bonds. For the three months ended September 30, 2020 and 2019, these sales resulted in realized losses of less than $0.1 million and realized gains of less than $0.1 million, respectively. For the nine months ended September 30, 2020 and 2019, the Company received total proceeds, less the amount of interest received of $6.0 million and $17.6 million, respectively, from sales of available-for-sale municipal bonds. For the nine months ended September 30, 2020 and 2019, these sales resulted in realized losses of $0.1 million and realized gains of $0.1 million, respectively, which were recorded in “Other income – Investment and other income, net” in the Consolidated Statements of Comprehensive Income. The basis for the sale of these securities was the specific identification of each bond sold during the period.
The investments under the funded deferred compensation plan are accounted for as trading securities and unrealized gains or losses are included in earnings. The fair value of these investments are determined based on quoted market prices (Level 1). For the three months ended September 30, 2020 and 2019, the Company’s recognized unrealized gains of $3.2 million and less than $0.1 million, respectively, related to equity securities still held at the respective reporting dates. For the nine months ended September 30, 2020 and 2019, the Company's recognized unrealized gains of $4.2 million and of $5.0 million, respectively, related to equity securities still held at the respective reporting dates.
The following tables provide fair value measurement information for the Company’s marketable securities and deferred compensation fund investments as of September 30, 2020 and December 31, 2019:

| As of September 30, 2020 |  |  |  |  |  |  |  |
|  |  |  |  | Fair Value Measurement Using: |  |  |  |
| Carrying Amount |  | Total Fair Value |  | Quoted Prices in Active Markets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
| (in thousands) |  |  |  |  |  |  |  |
Financial Assets: |  |  |  |  |  |  |  |  |
Marketable securities |  |  |  |  |  |  |  |  |
Municipal bonds — available-for-sale | $ | 94,042 |  |  | $ | 94,042 |  |  | $ | — |  |  | $ | 94,042 |  |  | $ | — |
Deferred compensation fund |  |  |  |  |  |  |  |  |
Money Market 1 | $ | 2,467 |  |  | $ | 2,467 |  |  | $ | — |  |  | $ | 2,467 |  |  | $ | — |
Balanced and Lifestyle | 9,412 |  |  | 9,412 |  |  | 9,412 |  |  | — |  |  | — |
Large Cap Growth | 15,471 |  |  | 15,471 |  |  | 15,471 |  |  | — |  |  | — |
Small Cap Growth | 4,096 |  |  | 4,096 |  |  | 4,096 |  |  | — |  |  | — |
Fixed Income | 4,737 |  |  | 4,737 |  |  | 4,737 |  |  | — |  |  | — |
International | 1,878 |  |  | 1,878 |  |  | 1,878 |  |  | — |  |  | — |
Mid Cap Growth | 2,908 |  |  | 2,908 |  |  | 2,908 |  |  | — |  |  | — |
Deferred compensation fund | $ | 40,969 |  |  | $ | 40,969 |  |  | $ | 38,502 |  |  | $ | 2,467 |  |  | $ | — |

19

Table of Contents

| As of December 31, 2019 |  |  |  |  |  |  |  |
|  |  |  |  | Fair Value Measurement Using: |  |  |  |
| Carrying Amount |  | Total Fair Value |  | Quoted Prices in Active Markets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
| (in thousands) |  |  |  |  |  |  |  |
Financial Assets: |  |  |  |  |  |  |  |  |
Marketable securities |  |  |  |  |  |  |  |  |
Municipal bonds — available-for-sale | $ | 90,711 |  |  | $ | 90,711 |  |  | $ | — |  |  | $ | 90,711 |  |  | $ | — |
Deferred compensation fund |  |  |  |  |  |  |  |  |
Money Market 1 | $ | 2,625 |  |  | $ | 2,625 |  |  | $ | — |  |  | $ | 2,625 |  |  | $ | — |
Balanced and Lifestyle | 10,294 |  |  | 10,294 |  |  | 10,294 |  |  | — |  |  | — |
Large Cap Growth | 11,369 |  |  | 11,369 |  |  | 11,369 |  |  | — |  |  | — |
Small Cap Growth | 4,120 |  |  | 4,120 |  |  | 4,120 |  |  | — |  |  | — |
Fixed Income | 4,072 |  |  | 4,072 |  |  | 4,072 |  |  | — |  |  | — |
International | 1,932 |  |  | 1,932 |  |  | 1,932 |  |  | — |  |  | — |
Mid Cap Growth | 2,835 |  |  | 2,835 |  |  | 2,835 |  |  | — |  |  | — |
Deferred compensation fund | $ | 37,247 |  |  | $ | 37,247 |  |  | $ | 34,622 |  |  | $ | 2,625 |  |  | $ | — |

1.The fair value of the money market fund is based on the net asset value (“NAV”) of the shares held by the plan at the end of the period. The money market fund includes short-term United States dollar denominated money market instruments and the NAV is determined by the custodian of the fund. The money market fund can be redeemed at its NAV at the measurement date as there are no significant restrictions on the ability to sell this investment.

| Amortized Cost |  | Gross Unrealized Gains |  | Gross Unrealized Losses |  | Estimated Fair Value |  | Other-than-temporary Impairments
| (in thousands) |  |  |  |  |  |  |  |
September 30, 2020 |  |  |  |  |  |  |  |  |
Type of security: |  |  |  |  |  |  |  |  |
Municipal bonds — available-for-sale | $ | 87,868 |  |  | $ | 6,178 |  |  | $ | (4) |  |  | $ | 94,042 |  |  | $ | — |
Total debt securities | $ | 87,868 |  |  | $ | 6,178 |  |  | $ | (4) |  |  | $ | 94,042 |  |  | $ | — |
December 31, 2019 |  |  |  |  |  |  |  |  |
Type of security: |  |  |  |  |  |  |  |  |
Municipal bonds — available-for-sale | $ | 87,016 |  |  | $ | 3,695 |  |  | $ | — |  |  | $ | 90,711 |  |  | $ | — |
Total debt securities | $ | 87,016 |  |  | $ | 3,695 |  |  | $ | — |  |  | $ | 90,711 |  |  | $ | — |

The following table summarizes the contractual maturities of debt securities held at September 30, 2020 and December 31, 2019, which are classified as marketable securities in the Consolidated Balance Sheets:

|  | Municipal Bonds — Available-for-Sale |  |
Contractual maturity: |  | September 30, 2020 |  | December 31, 2019
|  | (in thousands) |  |
Maturing in one year or less |  | $ | 1,514 |  |  | $ | 876 |
Maturing in second year through fifth year |  | 21,998 |  |  | 16,071 |
Maturing in sixth year through tenth year |  | 40,583 |  |  | 38,801 |
Maturing after ten years |  | 29,947 |  |  | 34,963 |
Total debt securities |  | $ | 94,042 |  |  | $ | 90,711 |

20

Table of Contents
Note 10—Shared-Based Compensation
The components of the Company’s shared-based compensation expense for the nine months ended September 30, 2020 and 2019 are as follows:

| Nine Months Ended September 30, |  |
| 2020 |  | 2019
| (in thousands) |  |
Stock options | $ | 1,594 |  |  | $ | 1,970 |
Restricted stock and restricted stock units | 3,898 |  |  | 2,980 |
Employee Stock Purchase Plan | 425 |  |  | 518 |
Total pre-tax share-based compensation expense charged against income1 | $ | 5,917 |  |  | $ | 5,468 |

1.Share-based compensation expense is recorded in cost of services and selling, general and administrative expense in the Company’s Consolidated Statements of Comprehensive Income.
At September 30, 2020, the unrecognized compensation cost related to unvested stock options and awards was $18.5 million. The weighted average period over which these awards will vest is approximately 2.9 years.
2020 Omnibus Incentive Plan
On May 26, 2020, the Company adopted the 2020 Omnibus Incentive Plan (the "2020 Plan") after approval by the Company's Shareholders at the Annual Meeting of Shareholders. The 2020 Plan provides that current or prospective officers, employees, non-employee directors and advisors can receive share-based awards such as stock options, performance stock units, restricted stock units and other stock awards. The 2020 Plan seeks to encourage profitability and growth of the Company through short-term and long-term incentives that are consistent with the Company's operating objectives.
As of September 30, 2020, there were 5.2 million shares of common stock reserved for issuance under the 2020 Plan, of which, 2.5 million are available for future grant. The amount of shares available for issuance under the 2020 Plan will increase when outstanding awards under the Company's Second Amended and Restated 2012 Equity Incentive Plan (the “2012 Plan”) are subsequently forfeited, terminated, lapsed, or satisfied thereunder in cash or property other than shares. No stock award will have a term in excess of 10 years. The Nominating, Compensation and Stock Option Committee of the Board of Directors is responsible for determining the terms of the grants in accordance with the 2020 Plan.
2012 Equity Incentive Plan
The 2012 Plan was replaced by the 2020 Plan on May 26, 2020. Accordingly, no new equity awards will be granted under the 2012 Plan.
Stock Options
A summary of stock options outstanding under as of December 31, 2019 and changes during the nine months ended September 30, 2020 are as follows:

| Stock Options Outstanding |  |
| Number of Shares |  | Weighted Average Exercise Price
| (in thousands) |  |
December 31, 2019 | 2,107 |  |  | $ | 32.99 |
Granted | 215 |  |  | $ | 24.49 |
Exercised | (101) |  |  | $ | 17.72 |
Forfeited | (12) |  |  | $ | 37.66 |
Expired | (46) |  |  | $ | 32.18 |
September 30, 2020 | 2,163 |  |  | $ | 32.85 |

The weighted average grant-date fair value of stock options granted during the nine months ended September 30, 2020 and 2019 was $4.65 and $8.18 per common share, respectively. The total intrinsic value of stock options exercised during the nine months ended September 30, 2020 and 2019 was $0.9 million and $1.5 million, respectively.
21

Table of Contents
The fair value of stock option awards granted in 2020 and 2019 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:

| Nine Months Ended September 30, |  |
| 2020 |  | 2019
Risk-free interest rate | 1.8 | % |  | 2.5 | %
Weighted average expected life | 6.6 years |  | 5.7 years
Expected volatility | 26.6 | % |  | 22.6 | %
Dividend yield | 3.2 | % |  | 1.9 | %

The following table summarizes other information about the stock options at September 30, 2020:

| September 30, 2020
| (amounts in thousands, except per share data)
Outstanding: |
Aggregate intrinsic value | $ | 809 |
Weighted average remaining contractual life | 5.4 years
Exercisable: |
Number of options | 1,440 |
Weighted average exercise price | $ | 31.09 |
Aggregate intrinsic value | $ | 809 |
Weighted average remaining contractual life | 4.2 years

Restricted Stock Units and Restricted Stock
The fair value of outstanding restricted stock units and restricted stock was determined based on the market price of the shares on the date of grant. During the nine months ended September 30, 2020, the Company granted 0.3 million restricted stock units with a weighted average grant date fair value of $24.43 per unit. During the nine months ended September 30, 2019, the Company granted 0.2 million restricted stock units with a weighted average grant date fair value of $40.49 per unit.
During the nine months ended September 30, 2020 and 2019, the Company did not grant any restricted stock.
A summary of the outstanding restricted stock units and restricted stock as of December 31, 2019 and changes during the nine months ended September 30, 2020 is as follows:

| Restricted Stock Units and Restricted Stock |  |
| Number |  | Weighted Average Grant Date Fair Value
| (in thousands) |  |
December 31, 2019 | 362 |  |  | $ | 43.24 |
Granted | 307 |  |  | $ | 24.43 |
Vested | (94) |  |  | $ | 42.40 |
Forfeited | (13) |  |  | $ | 32.83 |
September 30, 2020 | 562 |  |  | $ | 33.33 |

Employee Stock Purchase Plan
The Company’s Employee Stock Purchase Plan ("ESPP") is currently available through 2021 to all eligible employees. All full-time and part-time employees who work an average of 20 hours per week and have completed two years of continuous service with the Company are eligible to participate. Annual offerings commence and terminate on the respective year’s first and last calendar day.
Under the ESPP, the Company is authorized to issue up to 4.1 million shares of its common stock to its employees. Pursuant to such authorization, there are 2.1 million shares available for future grant at September 30, 2020.
22

Table of Contents
The expense associated with the options granted under the ESPP during the nine months ended September 30, 2020 and 2019 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:

| Nine Months Ended September 30, |  |
| 2020 |  | 2019
Risk-free interest rate | 1.6% |  | 2.6%
Weighted average expected life (years) | 1.0 |  | 1.0
Expected volatility | 42.0% |  | 30.8%
Dividend yield | 3.3% |  | 1.9%

Deferred Compensation Plan
The Company offers a Supplemental Executive Retirement Plan (“SERP”) for executives and certain key employees. The SERP allows participants to defer a portion of their earned income on a pre-tax basis and as of the last day of each plan year, each participant will be credited with a match of a portion of their deferral in the form of the Company’s common stock based on the then-current market value. Under the SERP, the Company is authorized to issue 1.0 million shares of its common stock to its employees. Pursuant to such authorization, the Company has 0.4 million shares available for future grant at September 30, 2020. At the time of issuance, such shares are accounted for at cost as treasury stock.
The following table summarizes information about the SERP during the nine months ended September 30, 2020 and 2019:

| Nine Months Ended September 30, |  |
| 2020 |  | 2019
| (in thousands) |  |
SERP expense 1 | $ | 444 |  |  | $ | 497 |
Unrealized gain recorded in SERP liability account | $ | 3,973 |  |  | $ | 4,964 |

1.Both the SERP match and the deferrals are included in the selling, general and administrative caption in the Consolidated Statements of Comprehensive Income.
Note 11—Dividends
During the nine months ended September 30, 2020, the Company paid regular quarterly cash dividends totaling approximately $45.4 million as follows:

| Quarter Ended |  |  |  |
| September 30, 2020 |  | June 30, 2020 |  | March 31, 2020
| (in thousands, except per share data) |  |  |  |
Cash dividend paid per common share | $ | 0.20375 |  |  | $ | 0.20250 |  |  | $ | 0.20125 |
Total cash dividends paid | $ | 15,222 |  |  | $ | 15,128 |  |  | $ | 15,033 |
Record date | August 21, 2020 |  | May 22, 2020 |  | February 28, 2020
Payment date | September 25, 2020 |  | June 26, 2020 |  | March 27, 2020

Additionally, on October 21, 2020, the Company’s Board of Directors declared a regular quarterly cash dividend of $0.20500 per common share, which will be paid on December 24, 2020, to shareholders of record as of the close of business on November 20, 2020.
Cash dividends declared for the periods presented were as follows:

| Three Months Ended September 30, |  |  |  | Nine Months Ended September 30, |  |
| 2020 |  | 2019 |  | 2020 |  | 2019
Cash dividends declared per common share | $ | 0.20500 |  |  | $ | 0.20000 |  |  | $ | 0.61125 |  |  | $ | 0.59625 |

23

Table of Contents
Note 12—Income Taxes
The Company’s annual effective tax rate is impacted by the tax effects of option exercises and vested awards, which are treated as discrete items in the reporting period in which they occur, and therefore cannot be considered in the calculation of the estimated annual effective tax rate. The impact on the Company’s income tax provision through the nine months ended September 30, 2020 for such discrete items was not material.
Differences between the effective tax rate and the applicable U.S. federal statutory rate arise primarily from the effect of state and local income taxes, share-based compensation and tax credits available to the Company. The actual 2020 effective tax rate will likely vary from the estimate depending on the actual operating income earned with availability of tax credits and the exercise of stock options and vesting of share-based awards. The Company’s estimate for the 2020 effective tax rate has not been adjusted for any impacts related to COVID-19.
The Company accounts for income taxes using the asset and liability method, which results in recognizing income tax expense based on the amount of income taxes payable or refundable for the current year. Additionally, the Company regularly evaluates the tax positions taken or expected to be taken resulting from financial statement recognition of certain items. Based on the evaluation, there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. The evaluation was performed for the tax years ended December 31, 2016 through 2019 (with regard to U.S. federal income tax returns) and December 31, 2015 through 2019 (with regard to various state and local income tax returns), the tax years which remain subject to examination by major tax jurisdictions as of September 30, 2020.
The Company may from time to time be assessed interest or penalties by taxing jurisdictions, although any such assessments historically have been minimal. When the Company has received an assessment for interest and/or penalties, it will be classified in the financial statements as selling, general and administrative expense. In addition, any interest or penalties relating to recognized uncertain tax positions would also be recorded in selling, general and administrative expense.
Note 13—Segment Information
The Company manages and evaluates its operations in two reportable segments: Housekeeping (housekeeping, laundry, linen and other services) and Dietary (dietary department services). Although both segments serve the same customer base and share many operational similarities, they are managed separately due to distinct differences in the type of services provided, as well as the specialized expertise required of the professional management personnel responsible for delivering each segment’s services. Such services are rendered pursuant to discrete contracts, specific to each reportable segment.
24

Table of Contents
The Company’s accounting policies for the segments are generally the same as described in the Company’s significant accounting policies. Differences between the reportable segments’ operating results and other disclosed data and the information in the consolidated financial statements relate primarily to corporate level transactions and recording of transactions at the reportable segment level using other than generally accepted accounting principles. There are certain inventories and supplies that are primarily expensed when incurred within the operating segments, while they are capitalized in the consolidated financial statements. In addition, most corporate expenses such as corporate salary and benefit costs, certain legal costs, debt expense, information technology costs, depreciation, amortization of finite-lived intangible assets, share based compensation costs and other corporate-specific costs, are not fully allocated to the operating segments. There are also allocations for workers’ compensation and general liability expense within the operating segments that differ from the actual expense recorded by the Company under U.S. GAAP. Segment amounts disclosed are prior to elimination entries made in consolidation.

| Three Months Ended September 30, |  |  |  | Nine Months Ended September 30, |  |
| 2020 |  | 2019 |  | 2020 |  | 2019
| (in thousands) |  |  |  |  |  |
Revenues |  |  |  |  |  |  |
Housekeeping | $ | 223,423 |  |  | $ | 225,347 |  |  | $ | 675,366 |  |  | $ | 687,392 |
Dietary | 212,524 |  |  | 230,259 |  |  | 661,760 |  |  | 706,426 |
Total | $ | 435,947 |  |  | $ | 455,606 |  |  | $ | 1,337,126 |  |  | $ | 1,393,818 |
Income before income taxes |  |  |  |  |  |  |
Housekeeping | $ | 24,784 |  |  | $ | 21,698 |  |  | $ | 73,983 |  |  | $ | 73,009 |
Dietary | 19,630 |  |  | 8,828 |  |  | 52,627 |  |  | 33,966 |
Corporate and eliminations1 | (7,282) |  |  | (6,810) |  |  | (32,284) |  |  | (47,750) |
Total | $ | 37,132 |  |  | $ | 23,716 |  |  | $ | 94,326 |  |  | $ | 59,225 |

1.Primarily represents corporate office costs and related overhead, recording of certain inventories and supplies and workers compensation costs at the reportable segment level which use accounting methods that differ from those used at the corporate level, as well as consolidated subsidiaries’ operating expenses that are not allocated to the reportable segments, net of investment and other income and interest expense.
Note 14—Earnings Per Common Share
Basic and diluted earnings per common share are computed by dividing net income by the weighted-average number of basic and diluted common shares outstanding, respectively. The weighted-average number of diluted common shares includes the impact of dilutive securities, including outstanding stock options and unvested restricted stock and restricted stock units. The table below reconciles the weighted-average basic and diluted common shares outstanding:

| Three Months Ended September 30, |  |  |  | Nine Months Ended September 30, |  |
| 2020 |  | 2019 |  | 2020 |  | 2019
| (in thousands) |  |  |  |  |  |
Weighted average number of common shares outstanding - basic | 74,700 |  |  | 74,387 |  |  | 74,684 |  |  | 74,347 |
Effect of dilutive securities 1 | 77 |  |  | 120 |  |  | 84 |  |  | 268 |
Weighted average number of common shares outstanding - diluted | 74,777 |  |  | 74,507 |  |  | 74,768 |  |  | 74,615 |

1.Certain outstanding equity awards are anti-dilutive and therefore were excluded from the calculation of the weighted average number of diluted common shares outstanding.
Anti-dilutive outstanding equity awards under share-based compensation plans were as follows:

| Three Months Ended September 30, |  |  |  | Nine Months Ended September 30, |  |
| 2020 |  | 2019 |  | 2020 |  | 2019
| (in thousands) |  |  |  |  |  |
Anti-dilutive | 2,244 |  |  | 2,028 |  |  | 2,145 |  |  | 1,512 |

25

Table of Contents
Note 15—Other Contingencies
Line of Credit
At September 30, 2020, the Company had a $475 million bank line of credit on which to draw for general corporate purposes. Amounts drawn under the line of credit are payable upon demand and generally bear interest at a float rate, based on the Company’s leverage ratio, and starting at LIBOR plus 115 basis points (or if LIBOR becomes unavailable, the higher of the Overnight Bank Funding Rate, plus 50 basis points and the Prime Rate). As of September 30, 2020 there were no borrowings under the line of credit. As of December 31, 2019 there were $10.0 million in borrowings under the line of credit. The line of credit requires the Company to satisfy two financial covenants, with which the Company is in compliance as of September 30, 2020. The line of credit expires on December 21, 2023.
At September 30, 2020, the Company also had outstanding $64.9 million in irrevocable standby letters of credit, which relate to payment obligations under the Company’s insurance programs. In connection with the issuance of the letters of credit, the amount available under the line of credit was reduced by $64.9 million to $410.1 million at September 30, 2020. The letters of credit expire on January 2, 2021. Besides the $64.9 million letters of credit there are no other restrictions as to the amount which the Company can draw upon the $475 million line of credit.
Tax Jurisdictions and Matters
The Company provides services throughout the continental United States and is subject to numerous state and local taxing jurisdictions. In the ordinary course of business, a jurisdiction may contest the Company’s reporting positions with respect to the application of its tax code to the Company’s services, which could result in additional tax liabilities.
The Company has tax matters with various taxing authorities. Because of the uncertainties related to both the probable outcomes and amount of probable assessments due, the Company is unable to make a reasonable estimate of a liability. The Company does not expect the resolution of any of these matters, taken individually or in the aggregate, to have a material adverse effect on the consolidated financial position or results of operations based on the Company’s best estimate of the outcomes of such matters.
Legal Proceedings
The Company is subject to various claims and legal actions in the ordinary course of business. Some of these matters include payroll and employee-related matters and examinations by governmental agencies. As the Company becomes aware of such claims and legal actions, the Company records accruals for any exposures that are probable and estimable. If adverse outcomes of such claims and legal actions are reasonably possible, Management assesses materiality and provides financial disclosure, as appropriate.
As previously disclosed, the Securities and Exchange Commission (“SEC”) is conducting an investigation into the Company’s earnings per share (“EPS”) calculation practices. Following receipt of a letter from the SEC in November 2017 regarding its inquiry into those practices followed by a subpoena in March 2018, the Company authorized its outside counsel to conduct an internal investigation, under the direction of the Company’s Audit Committee, into matters related to the SEC subpoena. This investigation was completed in March 2019 and the Company continues to cooperate with the SEC’s investigation and document requests.
On March 22, 2019, a putative shareholder class action lawsuit was filed against the Company and its Chief Executive Officer in the U.S. District Court for the Eastern District of Pennsylvania. The initial complaint, which was filed by a plaintiff purportedly on behalf of all purchasers of the Company’s securities between April 11, 2017 and March 4, 2019 (the "Class Period"), alleges violations of the federal securities laws in connection with the matters related to the Company’s EPS calculation practices. On September 17, 2019, the complaint was amended to, among other things, extend the Class Period to cover the period between April 8, 2014 and March 4, 2019, and to name additional individuals affiliated with the Company as defendants. The lead plaintiff seeks unspecified monetary damages and other relief on behalf of the plaintiff class.
While the Company is vigorously defending against all litigation claims asserted, this litigation—along with the ongoing SEC investigation—could result in substantial costs to the Company and a diversion of the Company’s management’s attention and resources, which could harm its business. In addition, the uncertainty of the pending lawsuit or potential filing of additional lawsuits could lead to more volatility and a reduction in the Company’s stock price. At this time the Company is unable to reasonably estimate possible losses or form a judgment that an unfavorable outcome is either probable or remote. It is not
26

Table of Contents
currently possible to assess whether or not the outcome of these proceedings may have a material adverse effect on the Company.
Government Regulations
The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care many of whom have been significantly impacted by COVID-19. For those customers who were impacted, the pandemic has resulted in increased operating costs, reductions in new resident admitants, and reduced census. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or additional changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. There have been several enacted and proposed federal and state relief measures as a result of COVID-19 which should provide support for these customers during this pandemic, however, the full benefit of any such programs would not be realized until these programs are fully implemented, government agencies issue applicable regulations or guidance and such relief is provided.
Note 16—Subsequent Events
The Company evaluated all subsequent events through the filing date of this Form 10-Q. There were no events or transactions occurring during this subsequent reporting period which require recognition or additional disclosure in these financial statements.
27

Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Results of Operations
The following discussion is intended to provide the reader with information that will be helpful in understanding our financial statements, including the changes in certain key items when comparing financial statements period to period. We also intend to provide the primary factors that accounted for those changes, as well as a summary of how certain accounting principles affect our financial statements. In addition, we are providing information about the financial results of our two operating segments to further assist in understanding how these segments and their results affect our consolidated results of operations. This discussion should be read in conjunction with our financial statements as of September 30, 2020 and December 31, 2019 and the notes accompanying those financial statements.
COVID-19 Considerations
The Company’s priorities during the COVID-19 pandemic are protecting the health and safety of our employees; maximizing the impact of our main services in helping customers with the housekeeping and dietary services needs of their facilities, and deploying the talents of our employees and our resources to help the communities we serve meet and overcome the current challenges. In the quarter ended September 30, 2020, the COVID-19 pandemic did not have a material net impact on our consolidated operating results. Revenues for the quarter ended September 30, 2020 included $9.1 million of COVID-19 supplemental billings, primarily related to employee pay premiums passed through to customers, which were offset by temporary decreases in recurring billings as a result of census-driven cost reductions in staffing and purchasing. In the future, the pandemic may cause reduced demand for our services if, for example, the pandemic results in a recessionary economic environment to the long-term care and skilled nursing industries in which we serve; however since the services that we offer are essential to our customers, we believe that over the long term, there will continue to be strong demand for our services.
Our ability to operate without significant negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees, with particular measures in place for those working in our customer facilities. For the nine months ended September 30, 2020, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with nursing departments to do our part in the infection prevention and control continuum and remain flexible in responding to our customer-partners. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.
Through September 30, 2020, we continue to generate operating cash flows to meet our short-term liquidity needs, and we expect to maintain access to the capital markets. We have also not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.
For additional information on risk factors related to the pandemic or other risks that could impact our results, please refer to “Risk Factors” in Part II, Item 1A of this Form 10-Q.
Overview
We provide management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of healthcare facilities, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. We believe we are the largest provider of housekeeping and laundry management services to the long-term care industry in the United States, rendering such services to over 3,000 facilities throughout the continental United States as of September 30, 2020.
We provide services primarily pursuant to full service agreements with our customers. Under such agreements, we are responsible for the day-to-day management of the employees located at our customers’ facilities, as well as for the provision of certain supplies. We also provide services on the basis of management-only agreements for a limited number of customers. Under a management-only agreement, we provide management and supervisory services while the customer facility retains payroll responsibility for the non-supervisory staff. Our agreements with customers typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.
We are organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”).
28

Table of Contents
Housekeeping consists of managing our customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the customers’ facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the customers’ facilities. Upon beginning service with a customer facility, we typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate housekeeping services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation.
Dietary consists of managing our customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. On-site management is responsible for all daily dietary department activities, with regular support provided by a District Manager specializing in dietary services. We also offer clinical consulting services to our dietary customers, which may be provided as a stand-alone service, or bundled with other dietary department services. Upon beginning service with a customer facility, we typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate dietitian services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation.
At September 30, 2020, Housekeeping services were provided at essentially all of our approximately 3,000 customer facilities, generating approximately 50.5% or $675.4 million of our total revenues for the nine months ended September 30, 2020. Dietary services were provided to over 1,500 customer facilities at September 30, 2020 and contributed approximately 49.5% or $661.8 million of our total revenues for the nine months ended September 30, 2020.
29

Table of Contents
Three Months Ended September 30, 2020 and 2019
The following table summarizes the income statement key components that we use to evaluate our financial performance on a consolidated and reportable segment basis, for the three months ended September 30, 2020 and 2019. The differences between the reportable segments’ operating results and other disclosed data and our consolidated financial results relate primarily to corporate level transactions and adjustments related to transactions recorded at the reportable segment level which use methods other than generally accepted accounting principles.

| Three Months Ended September 30, |  |  |  |
| 2020 |  | 2019 |  | % Change
| (in thousands) |  |  |  |
Revenues |  |  |  |  |
Housekeeping | $ | 223,423 |  |  | $ | 225,347 |  |  | (0.9) | %
Dietary | 212,524 |  |  | 230,259 |  |  | (7.7) | %
Consolidated | $ | 435,947 |  |  | $ | 455,606 |  |  | (4.3) | %
Costs of services provided |  |  |  |  |
Housekeeping | $ | 198,639 |  |  | $ | 203,649 |  |  | (2.5) | %
Dietary | 192,894 |  |  | 221,431 |  |  | (12.9) | %
Corporate and eliminations | (26,090) |  |  | (26,676) |  |  | (2.2) | %
Consolidated | $ | 365,443 |  |  | $ | 398,404 |  |  | (8.3) | %
Selling, general and administrative expense |  |  |  |  |
Corporate and eliminations | $ | 37,337 |  |  | $ | 33,479 |  |  | 11.5 | %
Investment and other income, net |  |  |  |  |
Corporate and eliminations | $ | 4,279 |  |  | $ | 733 |  |  | 483.8 | %
Interest expense |  |  |  |  |
Corporate and eliminations | $ | (314) |  |  | $ | (740) |  |  | (57.6) | %
Income (loss) before income taxes |  |  |  |  |
Housekeeping | $ | 24,784 |  |  | $ | 21,698 |  |  | 14.2 | %
Dietary | 19,630 |  |  | 8,828 |  |  | 122.4 | %
Corporate and eliminations | (7,282) |  |  | (6,810) |  |  | (6.9) | %
Consolidated | $ | 37,132 |  |  | $ | 23,716 |  |  | 56.6 | %

Housekeeping and Dietary revenues represented approximately 51.3% and 48.7% of consolidated revenues for the three months ended September 30, 2020, respectively.
30

Table of Contents
The following table sets forth the ratio of certain items to consolidated revenues:

| Three Months Ended September 30, |  |
| 2020 |  | 2019
Revenues | 100.0 | % |  | 100.0 | %
Operating costs and expenses: |  |  |
Costs of services provided | 83.8 | % |  | 87.4 | %
Selling, general and administrative expense | 8.6 | % |  | 7.3 | %
Other income (expense): |  |  |
Investment and other income, net | 1.0 | % |  | 0.2 | %
Interest expense | (0.1) | % |  | (0.2) | %
Income before income taxes | 8.5 | % |  | 5.3 | %
Income tax | 2.2 | % |  | 1.2 | %
Net income | 6.3 | % |  | 4.1 | %

Revenues
Consolidated
Consolidated revenues decreased 4.3% to $435.9 million for the three months ended September 30, 2020 compared to $455.6 million for the corresponding period in 2019, as a result of the factors discussed below under Reportable Segments.
Reportable Segments
Housekeeping and Dietary revenues decreased 0.9% and 7.7%, respectively, during the three months ended September 30, 2020 compared to the corresponding period in 2019, primarily driven by the Company exiting facilities in the latter half of 2019 in conjunction with operator transitions in which we were unable to come to agreeable terms. As of the three months ended September 30, 2020, our revenues included $9.1 million of COVID-19 supplemental billings, primarily related to employee pay premiums passed through to customers, offset by temporary decreases in recurring billings as a result of census-driven cost reductions in staffing and purchasing. The full impact that COVID-19 will have on our revenues is not yet known at this time.
Costs of Services Provided
Consolidated
Consolidated costs of services provided decreased 8.3% to $365.4 million for the three months ended September 30, 2020 compared to $398.4 million for the three months ended September 30, 2019. During the three months ended September 30, 2020, costs of services related to COVID-19 were primarily re-billed back to our customers. Future increases to both labor and supplies expense as a result of COVID-19 are possible, however we anticipate to be reimbursed from our customers for most COVID-19 related costs which are outside the scope of services or supplies which we are contractually obligated. The terms in our service agreements support this anticipation and the expectation of our customers' eligibility for additional reimbursement under enacted and proposed government regulations.
The following table provides a comparison of key indicators we consider when managing the consolidated costs of services provided:

|  | Three Months Ended September 30, |  |  |  |
Costs of Services Provided - Key Indicators as a % of Consolidated Revenue |  | 2020 |  | 2019 |  | Change
Bad debt provision |  | 0.2% |  | 0.3% |  | (0.1)%
Self-insurance costs |  | 2.7% |  | 2.9% |  | (0.2)%

The decrease in the bad debt provision was impacted by the current aging of our accounts receivables. Effective January 1, 2020, the Company adopted the ASC 326 accounting guidance which changed the Company’s procedures for estimating its bad debt provision. Under ASC 326, the Company now records a provision for bad debt based on management’s forecast of expected future credit losses. Prior to ASC 326, the Company recorded a provision for bad debt based solely on accounts and notes receivables which were identified as impaired.
31

Table of Contents
Reportable Segments
Costs of services provided for Housekeeping, as a percentage of Housekeeping revenues, decreased to 88.9% for the three months ended September 30, 2020 from 90.4% in the corresponding period in 2019. Costs of services provided for Dietary, as a percentage of Dietary revenues, decreased to 90.8% for the three months ended September 30, 2020 from 96.2% in the corresponding period in 2019.
The following table provides a comparison of the key indicators we consider when managing costs of services provided at the segment level, as a percentage of the respective segment’s revenues:

|  | Three Months Ended September 30, |  |  |  |
Costs of Services Provided - Key Indicators as a % of Segment Revenue |  | 2020 |  | 2019 |  | Change
Housekeeping labor and other labor-related costs |  | 80.5% |  | 80.9% |  | (0.4)%
Housekeeping supplies |  | 6.7% |  | 7.4% |  | (0.7)%
Dietary labor and other labor-related costs |  | 63.1% |  | 64.2% |  | (1.1)%
Dietary supplies |  | 25.8% |  | 29.4% |  | (3.6)%

Variations within these key indicators relate to the provision of services at new facilities and changes in the mix of customers for whom we provide supplies or do not provide supplies. Management focuses on building efficiencies and managing labor and other costs at the facility level, as well as managing supply chain costs, for new and existing facilities. The decline in the cost of dietary supplies as a percentage of dining revenues was driven by the mix of business where we no longer provide all dining department supplies, declining census and management of food-spend costs.
Consolidated Selling, General and Administrative Expense
Included in selling, general and administrative expense are gains and losses associated with changes in the value of investments under the deferred compensation plan. These investments represent the amounts held on behalf of the participating employees and changes in the value of these investments affect the amount of our deferred compensation liability. Gains on the plan investments during the three months ended September 30, 2020 and 2019 increased our total selling, general and administrative expense for those periods. During the three months ended September 30, 2020, we incurred an increase to certain costs related to COVID-19, however such costs were immaterial. There is a possibility for additional increased selling, general and administrative expense related to the pandemic but such costs at this time are not expected to be material.
Excluding the change in the deferred compensation plan described above, consolidated selling, general and administrative expense increased $0.7 million or 2.0% for the three months ended September 30, 2020 compared to the corresponding period in 2019. The increase was primarily a result of increased payroll costs and higher legal and professional fees incurred in connection with the Company's internal investigation related to the Securities and Exchange Commission's ("SEC") inquiry regarding the Company's earnings per share calculation practices, which was partially offset by a reduction in travel related expense.
The table below summarizes the changes in these components of selling, general and administrative expense:

| Three Months Ended September 30, |  |  |  |  |  |
| 2020 |  | 2019 |  | $ Change |  | % Change
| (dollar amounts in thousands) |  |  |  |  |  |
Selling, general and administrative expense excluding change in deferred compensation liability | $ | 34,127 |  |  | $ | 33,453 |  |  | $ | 674 |  |  | 2.0 | %
Gain on deferred compensation plan investments | 3,210 |  |  | 26 |  |  | 3,184 |  |  | 12,246.2 | %
Selling, general and administrative expense | $ | 37,337 |  |  | $ | 33,479 |  |  | $ | 3,858 |  |  | 11.5 | %

Consolidated Investment and Other Income, net
Investment and other income increased 483.8% to $4.3 million for the three months ended September 30, 2020 compared to the corresponding 2019 period, primarily due to market fluctuations in the value of our trading security investments representing the funding for our deferred compensation plan.
32

Table of Contents
Consolidated Interest Expense
Consolidated interest expense decreased 57.6% to $0.3 million for the three months ended September 30, 2020 compared to the corresponding 2019 period due to fewer interquarter borrowings.
Consolidated Income Taxes
During the three months ended September 30, 2020, the Company recognized a provision for income taxes of $9.5 million, or 25.6% effective tax rate, versus $5.4 million, or 22.7% effective tax rate, for the same period in 2019. The increase to the Company tax rate related to discrete items from stock compensation expense. The Company’s estimate for the 2020 effective tax rate has not been adjusted for any impact related to COVID-19 as the impact on the Company's effective tax rate at this time is not expected to be material.
The actual annual effective tax rate will be impacted by the tax effects of option exercises or vested awards, which are treated as discrete items in the reporting period in which they occur, and therefore cannot be considered in the calculation of the estimated annual effective tax rate. The impact on our income tax provision for the three months ended September 30, 2020 for such discrete items was not material.
33

Nine Months Ended September 30, 2020 and 2019
The following table summarizes the income statement key components that we use to evaluate our financial performance on a consolidated and reportable segment basis, for the nine months ended September 30, 2020 and 2019. The differences between the reportable segments’ operating results and other disclosed data and our consolidated financial results relate primarily to corporate level transactions and adjustments related to transactions recorded at the reportable segment level which use methods other than generally accepted accounting principles.

| Nine Months Ended September 30, |  |  |  |
| 2020 |  | 2019 |  | % Change
| (in thousands) |  |  |  |
Revenues |  |  |  |  |
Housekeeping | $ | 675,366 |  |  | $ | 687,392 |  |  | (1.7) | %
Dietary | 661,760 |  |  | 706,426 |  |  | (6.3) | %
Consolidated | $ | 1,337,126 |  |  | $ | 1,393,818 |  |  | (4.1) | %
Costs of services provided |  |  |  |  |
Housekeeping | $ | 601,383 |  |  | $ | 614,383 |  |  | (2.1) | %
Dietary | 609,133 |  |  | 672,460 |  |  | (9.4) | %
Corporate and eliminations | (70,400) |  |  | (60,689) |  |  | 16.0 | %
Consolidated | $ | 1,140,116 |  |  | $ | 1,226,154 |  |  | (7.0) | %
Selling, general and administrative expense |  |  |  |  |
Corporate and eliminations | $ | 108,819 |  |  | $ | 113,189 |  |  | (3.9) | %
Investment and other income, net |  |  |  |  |
Corporate and eliminations | $ | 7,197 |  |  | $ | 7,329 |  |  | (1.8) | %
Interest expense |  |  |  |  |
Corporate and eliminations | $ | (1,062) |  |  | $ | (2,579) |  |  | (58.8) | %
Income (loss) before income taxes |  |  |  |  |
Housekeeping | $ | 73,983 |  |  | $ | 73,009 |  |  | 1.3 | %
Dietary | 52,627 |  |  | 33,966 |  |  | 54.9 | %
Corporate and eliminations | (32,284) |  |  | (47,750) |  |  | (32.4) | %
Consolidated | $ | 94,326 |  |  | $ | 59,225 |  |  | 59.3 | %

34

The following table sets forth the ratio of certain items to consolidated revenues:

| Nine Months Ended September 30, |  |
| 2020 |  | 2019
Revenues | 100.0 | % |  | 100.0 | %
Operating costs and expenses: |  |  |
Costs of services provided | 85.3 | % |  | 88.0 | %
Selling, general and administrative expense | 8.1 | % |  | 8.1 | %
Other income (expense): |  |  |
Investment and other income, net | 0.5 | % |  | 0.5 | %
Interest expense | (0.1) | % |  | (0.2) | %
Income before income taxes | 7.0 | % |  | 4.2 | %
Income tax | 1.7 | % |  | 1.0 | %
Net income | 5.3 | % |  | 3.2 | %

Revenues
Consolidated
Consolidated revenues decreased 4.1% to $1.3 billion for the nine months ended September 30, 2020 compared to $1.4 billion for the corresponding period in 2019 as a result of the factors discussed below under Reportable Segments.
Reportable Segments
Housekeeping and Dietary revenues decreased 1.7% and 6.3%, respectively, during the nine months ended September 30, 2020 compared to the corresponding period in 2019, partially driven by the termination of several customers due to the Company exiting facilities in conjunction with operator transitions where we have been unable to come to agreeable terms, typically including accelerated payment and stricter credit terms with new operators.
Revenue for the nine months ended September 30, 2020 included $26.0 million of COVID-19 supplemental billings, primarily related to employee pay premiums passed through to customers, offset by temporary decreases in recurring billings as a result of census-driven cost reductions in staffing and purchasing. The full impact that COVID-19 will have on our revenues is not yet known at this time.
Costs of services provided
Consolidated
Consolidated costs of services provided decreased 7.0% to $1.1 billion for the nine months ended September 30, 2020 compared to $1.2 billion for the nine months ended September 30, 2019.
The following table provides a comparison of key indicators we consider when managing the consolidated costs of services provided:

|  | Nine Months Ended September 30, |  |  |  |
Costs of Services Provided - Key Indicators as a % of Consolidated Revenue |  | 2020 |  | 2019 |  | Change
Bad debt provision |  | 0.5% |  | 1.6% |  | (1.1)%
Self-insurance costs |  | 2.7% |  | 2.8% |  | (0.1)%

The decrease in the bad debt provision is related to our current assessment of the collectability of our accounts and notes receivable during the nine months ended September 30, 2020. Additionally we incurred higher than normal bad debt expense during the nine months ended September 30, 2019 due to the out-of-court restructuring of a privately held Northeast based operator that occurred during the first quarter of 2019. Effective January 1, 2020, the Company adopted the ASC 326 accounting guidance which changed the Company’s procedures for estimating its bad debt provision. Under ASC 326, the Company now records a provision for bad debt based on management’s forecast of expected future credit losses. Prior to ASC 326, the Company recorded a provision for bad debt based solely on accounts and notes receivables which were identified as impaired.
35

Reportable Segments
Costs of services provided for Housekeeping, as a percentage of Housekeeping revenues, decreased to 89.0% for the nine months ended September 30, 2020 from 89.4% in the corresponding period in 2019. Costs of services provided for Dietary, as a percentage of Dietary revenues, decreased to 92.0% for the nine months ended September 30, 2020 from 95.2% in the corresponding period in 2019.
The following table provides a comparison of the key indicators we consider when managing costs of services provided at the segment level, as a percentage of the respective segment’s revenues:

|  | Nine Months Ended September 30, |  |  |  |
Costs of Services Provided - Key Indicators as a % of Segment Revenue |  | 2020 |  | 2019 |  | Change
Housekeeping labor and other labor-related costs |  | 80.2% |  | 79.8% |  | 0.4%
Housekeeping supplies |  | 7.0% |  | 7.5% |  | (0.5)%
Dietary labor and other labor-related costs |  | 63.5% |  | 63.2% |  | 0.3%
Dietary supplies |  | 26.5% |  | 29.6% |  | (3.1)%

Variations within these key indicators relate to the provision of services at new facilities and changes in the mix of customers for whom we provide supplies or do not provide supplies. Management focuses on building efficiencies and managing labor and other costs at the facility level, as well as managing supply chain costs, for new and existing facilities. The decline in dietary supplies spend as a percentage of dining revenues was driven by the mix of business where we no longer provide all dining department supplies, declining census and management of food-spend costs.
Selling, General and Administrative Expense
Included in selling, general and administrative expense are gains and losses associated with changes in the value of investments under the deferred compensation plan. These investments represent the amounts held on behalf of the participating employees and changes in the value of these investments affect the amount of our deferred compensation liability. Gains on the plan investments during the nine months ended September 30, 2020 and 2019 increased our total selling, general and administrative expense for these periods. During the nine months ended September 30, 2020, we incurred an increase to certain costs related to COVID-19, however such costs were immaterial. There is a possibility for additional increased selling, general and administrative expense related to the pandemic.
Excluding the change in the deferred compensation plan described above, consolidated selling, general and administrative expense decreased $3.4 million or 3.1% for the nine months ended September 30, 2020 compared to the corresponding period in 2019. The decrease was primarily a result of higher legal and other professional fees incurred during 2019 in connection with the Company's internal investigation related to the SEC's inquiry regarding the Company's earnings per share calculation practices.
The table below summarizes the changes in these components of selling, general and administrative expense:

| Nine Months Ended September 30, |  |  |  |  |  |
| 2020 |  | 2019 |  | $ Change |  | % Change
| (dollar amounts in thousands) |  |  |  |  |  |
Selling, general and administrative expense excluding change in deferred compensation liability | $ | 104,846 |  |  | $ | 108,224 |  |  | $ | (3,378) |  |  | (3.1) | %
Gain on deferred compensation plan investments | 3,973 |  |  | 4,965 |  |  | (992) |  |  | (20.0) | %
Selling, general and administrative expense | $ | 108,819 |  |  | $ | 113,189 |  |  | $ | (4,370) |  |  | (3.9) | %

Consolidated Investment and Interest Income, net
Investment and other income decreased 1.8% to $7.2 million for the nine months ended September 30, 2020 compared to the corresponding 2019 period, primarily due to market fluctuations in the value of our trading security investments representing the funding for our deferred compensation plan.
36

Consolidated Interest Expense
Consolidated interest expense decreased 58.8% to $1.1 million for the nine months ended September 30, 2020 compared to the corresponding 2019 period due to fewer interquarter borrowings.
Consolidated Income Taxes
During the nine months ended September 30, 2020 and 2019, the Company recognized a provision for income taxes of $23.4 million, or 24.8% and $13.5 million or 22.9%, respectively. The increase to the Company tax rate related to discrete items from stock compensation expense. The Company’s estimate for the 2020 effective tax rate has not been adjusted for any impacts related to COVID-19 as the impact at this time is not expected to be material.
The actual annual effective tax rate will be impacted by the tax effects of option exercises or vested awards, which are treated as discrete items in the reporting period in which they occur, and therefore cannot be considered in the calculation of the estimated annual effective tax rate. The impact on our income tax provision for the nine months ended September 30, 2020 for such discrete items was not material.
Liquidity and Capital Resources
Cash generated through operations is our primary source of liquidity. At September 30, 2020, we had cash, cash equivalents and marketable securities of $204.0 million and working capital of $403.2 million, compared to December 31, 2019 cash, cash equivalents and marketable securities of $118.0 million and working capital of $367.1 million. Our current ratio was 4.0 to 1 at September 30, 2020 versus 3.5 to 1 at December 31, 2019. Marketable securities represent fixed income investments that are highly liquid and can be readily purchased or sold through established markets. Such securities are held by our captive insurance company to satisfy capital requirements of the state regulator related to captive insurance companies. Through September 30, 2020, the pandemic has not negatively impacted the Company’s liquidity position as of such date.
For the nine months ended September 30, 2020 and 2019, our cash flows were as follows:

| Nine Months Ended September 30, |  |
| 2020 |  | 2019
| (in thousands) |  |
Net cash provided by operating activities | $ | 141,549 |  |  | $ | 80,222 |
Net cash used in investing activities | $ | (4,862) |  |  | $ | (4,256) |
Net cash used in financing activities | $ | (54,096) |  |  | $ | (61,419) |

Operating Activities
Our primary sources of cash from operating activities are the revenues generated from our Housekeeping and Dietary services. Our primary uses of cash from operating activities are the funding of our payroll and other personnel-related costs, as well as the costs of supplies used in providing our services. For the nine months ended September 30, 2020 cash flow from operations included a $32.3 million increase which related to the deferral of payroll taxes under the CARES Act. Such deferral, along with the timing of cash receipts and cash payments, are the primary drivers of the period-over-period changes in net cash provided by operating activities.
We have not changed our expectations on future cash flows from operating activities due to COVID-19. We anticipate that several of our customers may experience changes in their cash flows however we will continue to pursue collections in accordance with our service agreements.
Investing Activities
Our principal uses of cash for investing activities are the purchases of marketable securities and capital expenditures such as those for housekeeping and food service equipment, computer software and equipment, and furniture and fixtures (see “Capital Expenditures” below for additional information). Such uses of cash are partially offset by proceeds from sales of marketable securities.
Our investments in marketable securities are primarily comprised of tax-exempt municipal bonds and are intended to achieve our goal of preserving principal, maintaining adequate liquidity and maximizing returns subject to our investment guidelines.
37

Table of Contents
Our investment policy limits investment to certain types of instruments issued by institutions primarily with investment-grade ratings and places restrictions on concentration by type and issuer.
Financing Activities
The primary use of cash for financing activities is the payment of dividends. We have paid regular quarterly cash dividends since the second quarter of 2003. During 2020, we paid regular quarterly cash dividends to shareholders totaling $45.4 million as follows:

| Quarter Ended |  |  |  |
| September 30, 2020 |  | June 30, 2020 |  | March 31, 2020
| (amounts in thousands, except per share data) |  |  |  |
Cash dividend paid per common share | $ | 0.20375 |  |  | $ | 0.20250 |  |  | $ | 0.20125 |
Total cash dividends paid | $ | 15,222 |  |  | $ | 15,128 |  |  | $ | 15,033 |
Record date | August 21, 2020 |  | May 22, 2020 |  | February 28, 2020
Payment date | September 25, 2020 |  | June 26, 2020 |  | March 27, 2020

The dividends paid to shareholders during the nine months ended September 30, 2020 were funded by cash generated from operations. Our Board of Directors reviews our dividend policy on a quarterly basis. Although there can be no assurance that we will continue to pay dividends or regarding the amount of future dividend payments, we expect to continue to pay a regular quarterly cash dividend. In connection with the establishment of our dividend policy, we adopted a Dividend Reinvestment Plan in 2003.
The primary source of cash from financing activities is the net borrowings under our bank line of credit. We borrow for general corporate purposes as needed throughout the year.
We remain authorized to repurchase 1.6 million shares of our common stock pursuant to previous Board of Directors’ authorization. During the three and nine months ended September 30, 2020 and 2019, we repurchased our common stock as part of the dividend reinvestment related to treasury shares held within the Deferred Compensation Plan. The number of shares and value of shares repurchased were immaterial for the three and nine months ended September 30, 2020 and 2019.
Line of Credit
At September 30, 2020, we had a $475 million bank line of credit on which to draw for general corporate purposes. Amounts drawn under the line of credit are payable upon demand and generally bear interest at a floating rate, based on our leverage ratio, and starting at LIBOR plus 115 basis points (or if LIBOR becomes unavailable, the higher of the Overnight Bank Funding Rate, plus 50 basis points and the Prime Rate). At September 30, 2020, there were no borrowings under the line of credit.
The line of credit requires us to satisfy two financial covenants. The covenants and their respective status at September 30, 2020 were as follows:

Covenant Descriptions and Requirements |  | As of September 30, 2020
Funded debt 1 to EBITDA 2 ratio: less than 3.50 to 1.00 |  | 0.22
EBITDA to Interest Expense ratio: not less than 3.00 to 1.00 |  | 71.13

1.All indebtedness for borrowed money including, but not limited to, capitalized lease obligations, reimbursement obligations in respect of letters of credit and guarantees of any such indebtedness.
2.Net income plus interest expense, income tax expense, depreciation, amortization, stock compensation expense and extraordinary non-recurring losses/gains.
As noted above, we were in compliance with our financial covenants at September 30, 2020 and we expect to remain in compliance. The line of credit expires on December 21, 2023. We believe that our existing capacity under the line of credit provides adequate liquidity considering the potential impact of COVID-19.
38

Table of Contents
LIBOR is expected to be discontinued after 2021. Our line of credit agreement provides procedures for determining a replacement or alternative rate in the event that LIBOR is unavailable. However, there can be no assurances as to whether such replacement or alternative rate will be more or less favorable than LIBOR. We intend to monitor the developments with respect to the potential phasing out of LIBOR after 2021 and will work with our lenders to ensure any transition away from LIBOR will have minimal impact on our financial condition. We however can provide no assurances regarding the impact of the discontinuation of LIBOR on the interest rate that we would be required to pay or on our financial condition.
At September 30, 2020, we also had outstanding $64.9 million in irrevocable standby letters of credit, which relate to payment obligations under our insurance programs.
Capital Expenditures
The level of capital expenditures is generally dependent on the number of new customers obtained. Such capital expenditures primarily consist of housekeeping and food service equipment purchases, laundry and linen equipment installations, computer hardware and software, and furniture and fixtures. Although we have no specific material commitments for capital expenditures through the end of calendar year 2020, we estimate that for 2020 we will have capital expenditures of approximately $4.0 million to $6.0 million, of which we have made $3.1 million through September 30, 2020. We believe that our cash from operations, existing cash and cash equivalents balance and credit line will be adequate for the foreseeable future to satisfy the needs of our operations and to fund our anticipated growth. However, should these sources not be sufficient, we would seek to obtain necessary capital from such sources as long-term debt or equity financing.
Material Off-Balance Sheet Arrangements
We have no material off-balance sheet arrangements, other than our irrevocable standby letter of credit previously discussed.
Critical Accounting Policies and Estimates
Our significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report on Form 10-K (the "Form 10-K") for the period ended December 31, 2019. As described in such notes, we recognize revenue in the period in which the performance obligation is satisfied. Refer to our Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Form 10-K.
In preparing our financial statements, management is required to make estimates and assumptions that, among other things, affect the reported amounts of assets, liabilities, revenue and expenses. These estimates and assumptions are most significant when they involve levels of subjectivity and judgment necessary to account for highly uncertain matters or matters susceptible to change, and where they can have a material impact on our financial condition and operating performance. If actual results were to differ materially from the estimates made, the reported results could be materially affected.
Critical accounting estimates and the related assumptions are evaluated periodically as conditions warrant, and changes to such estimates are recorded as new information or changed conditions require.
New Accounting Standard Updates
See Note 1—Description of Business and Significant Accounting Policies herein to the condensed consolidated financial statements for a full description of recent accounting standard updates, including the expected dates of adoption.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
At September 30, 2020, we had $204.0 million in cash, cash equivalents and marketable securities. The fair value of all of our cash equivalents and marketable securities are determined based on “Level 1” or “Level 2” inputs, which are based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. We place our cash investments in instruments that meet credit quality standards, as specified in our investment policy guidelines.
Investments in both fixed-rate and floating-rate investments carry a degree of interest rate risk. The market value of fixed rate securities may be adversely impacted by an increase in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may fall short of expectations due to changes in interest rates or if there is a decline in the fair value of our investments.
39

Table of Contents
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are intended to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), such as this Form 10-Q, is reported in accordance with Securities and Exchange Commission rules. Disclosure controls are also intended to ensure that such information is accumulated and communicated to Management, including the President and Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Based on their evaluation as of September 30, 2020, pursuant to Exchange Act Rule 13a-15(b), our Management, including our President and Chief Executive Officer and Chief Financial Officer, believe our disclosure controls and procedures (as defined in Exchange Act 13a-15(e)) are effective.
Changes in Internal Controls over Financial Reporting
There were no changes in the Company’s internal controls over financial reporting that occurred during the three or nine months ended September 30, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company continues to review its disclosure controls and procedures, including its internal control over financial reporting, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that the Company’s systems evolve with its business.
Certifications
Certifications of the Principal Executive Officer and Principal Financial and Accounting Officer regarding, among other items, disclosure controls and procedures are included as exhibits to this Form 10-Q.
40

Table of Contents
PART II — OTHER INFORMATION
Item 1. Legal Proceedings
In the normal course of business, the Company is involved in various administrative and legal proceedings, including labor and employment, contracts, personal injury, and insurance matters.
As previously disclosed, the SEC is conducting an investigation into our EPS calculation practices. Following receipt of a letter from the SEC in November 2017 regarding its inquiry into those practices followed by a subpoena in March 2018, we authorized our outside counsel to conduct an internal investigation, under the direction of the Company’s Audit Committee, into matters related to the SEC subpoena. This investigation was completed in March 2019 and we continue to cooperate with the SEC’s investigation and document requests.
On March 22, 2019, a putative shareholder class action lawsuit was filed against the Company and our Chief Executive Officer in the U.S. District Court for the Eastern District of Pennsylvania. The initial complaint, which was filed by a plaintiff purportedly on behalf of all purchasers of our securities between April 11, 2017 and March 4, 2019, alleges violations of the federal securities laws in connection with the matters related to our EPS calculation practices. On September 17, 2019, the complaint was amended to, among other things, extend the Class Period to cover the period between April 8, 2014 and March 4, 2019, and to name additional individuals affiliated with the Company as defendants. The lead plaintiff seeks unspecified monetary damages and other relief on behalf of the plaintiff class.
While the Company is vigorously defending against all litigation claims asserted, this litigation—along with the ongoing SEC investigation—could result in substantial costs to the Company and a diversion of the Company’s management’s attention and resources, which could harm its business. In addition, the uncertainty of the pending lawsuit or potential filing of additional lawsuits could lead to more volatility and a reduction in the Company’s stock price. At this time the Company is unable to reasonably estimate possible losses or form a judgment that an unfavorable outcome is either probable or remote.
In light of the uncertainties involved in such proceedings, the ultimate outcome of a particular matter could become material to the Company’s results of operations for a particular period depending on, among other factors, the size of the loss or liability imposed and the level of the Company’s operating income for that period.
Item 1A. Risk Factors
There have been no material changes from the risk factors set forth in Part I, Item 1A, "Risk Factors" of the 2019 Form 10-K except as set forth below. The risk factors set forth below supplement, and should be read together with, that section for disclosures regarding what we believe are the more significant risks and uncertainties related to our business.
COVID-19 and other pandemics, epidemics, or outbreaks of a contagious illness may adversely affect our operating results, cash flows and financial condition.
COVID-19 coronavirus outbreak and other pandemics, epidemics, or outbreaks of a contagious illness, and similar events, may cause harm to us, our employees, our customers, our vendors and supply chain partners, and financial institutions, which could have a material adverse effect on our results of operations, financial condition and cash flows. The impacts may include, but would not be limited to:
•Decreased availability and increased cost of supplies due to increased demand around essential cleaning supplies including disinfecting agents, personal protective equipment (“PPE”), and food and food-related products due to increased global demand and disruptions along the global supply chains of these manufactures and distributors;
•Disruption to operations due to the unavailability of employees due to illness, quarantines, risk of illness, travel restrictions or factors that limit our existing or potential workforce;
•Disruption to the availability of our key personnel due to travel restrictions;
•Our capacity to meet more stringent, medically-required procedures at customer facilities;
•Elevated employee turnover which may increase payroll expense and recruiting-related expenses;
•Decreased census in the nursing home and long-term care industry, which could increase our credit risk with customers; and
•Significant disruption of global financial markets, which could have a negative impact on us or our customers’ ability to access capital in the future.
41

Table of Contents
In addition, we have taken and will continue to take temporary precautionary measures intended to help minimize the risk of COVID-19 to our employees, including requiring administrative and other groups of our employees to work remotely, suspending non-essential travel and restricting attendance at industry events and in-person work-related meetings. Such measures could have a material adverse effect on our business.
The further spread of COVID-19, and the requirements to take action to help limit the spread of the virus, could impact the resources required to carry out our business as usual and may have a material adverse effect on our results of operations, financial condition and cash flows. The extent to which COVID-19 will impact our business and our financial results will depend on future developments, which are highly uncertain and cannot be predicted. Such developments may include the ongoing geographic spread of the virus, the severity of the disease, the duration of the outbreak and the type and duration of actions that may be taken by various governmental authorities in response to the outbreak and the impact on the United States and the global economy. Any of these developments, individually or in aggregate, could materially impact our business and our financial results and condition.
We may incur additional liabilities in our Paid Loss Retrospective Insurance Plan for general liability and workers’ compensation insurance related to COVID-19 which may adversely affect our operating results, cash flows and financial condition.
As a result of the impact of COVID-19, litigation claims, enforcement actions, regulatory actions and investigations arising from personal injury and loss of life, have been and may, in the future, be asserted against us. In the event that our known claims experience and/or industry trends result in an unfavorable change in initial estimates of costs to settle such claims resulting from, among other factors, the severity levels of reported claims and medical cost inflation, it would have an adverse effect on our consolidated results of operations, financial condition and cash flows. Although we engage third-party experts to assist us in estimating appropriate reserves, the determination of the required reserves is dependent upon significant actuarial judgments. Changes in our insurance reserves as a result of our periodic evaluation of the related liabilities may cause significant fluctuations in our operating results. We expect many of these claims and actions, or any settlement of these claims and actions, to be covered by insurance and historically the maximum amount of our liability, net of any insurance recoverables, has been limited to our self-insurance retention levels.
There have been no other material changes in the risk factors set forth in Part I, Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Not applicable.
Item 3. Defaults Upon Senior Securities
Not applicable.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
Not applicable.
42

Table of Contents
Item 6. Exhibits
The following exhibits are filed as part of this Report:

Exhibit Number |  | Description
31.1 |  | Certification of Principal Executive Officer pursuant to Section 302 of the Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act Act
31.2 |  | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
32.1 |  | Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act
101 |  | The following financial information from the Company’s Form 10-Q for the quarterly period ended September 30, 2020 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Statements of Cash Flows, (iv) Consolidated Statement of Stockholders’ Equity, and (v) Notes to Consolidated Financial Statements
104 |  | Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.)

43

Table of Contents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant had duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  |  |  |  | HEALTHCARE SERVICES GROUP, INC. |
|  | Date: | October 23, 2020 |  | /s/ Theodore Wahl |
|  |  |  |  | Theodore Wahl |
|  |  |  |  | President & Chief Executive Officer |
|  |  |  |  | (Principal Executive Officer) |
|  | Date: | October 23, 2020 |  | /s/ John C. Shea |
|  |  |  |  | John C. Shea |
|  |  |  |  | Chief Financial Officer |
|  |  |  |  | (Principal Financial and Accounting Officer) |

44